UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
|
Filed by the Registrant ☑
|
||
|
Filed by a Party other than the Registrant ☐
|
||
|
Check the appropriate box:
|
||
|
☐
|
Preliminary Proxy Statement
|
|
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
☑
|
Definitive Proxy Statement
|
|
|
☐
|
Definitive Additional Materials
|
|
|
☐
|
Soliciting Material Pursuant to §240.14a-12
|
|
|
NU SKIN ENTERPRISES, INC.
|
||
|
(Name of Registrant as Specified In Its Charter)
|
||
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
||
|
Payment of Filing Fee (Check the appropriate box):
|
||
|
☑
|
No fee required.
|
|
|
☐
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
Total fee paid:
|
|
|
☐
|
Fee paid previously with preliminary materials.
|
|
|
☐
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or
Schedule and the date of its filing.
|
|
|
(1)
|
Amount Previously Paid:
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
Filing Party:
|
|
|
(4)
|
Date Filed:
|
|
 |
|
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS OF
NU SKIN ENTERPRISES, INC.
|
NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders (the “Annual Meeting”) of Nu Skin Enterprises, Inc., a Delaware corporation, will be held at 11:00 a.m., Mountain Daylight Time,
on June 2, 2021. At the Annual Meeting, you will be asked to consider and vote on the following matters, which are more fully described in the proxy statement:
| 1. |
To elect the nine directors named in the proxy statement;
|
| 2. |
To hold an advisory vote to approve our executive compensation;
|
| 3. |
To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2021; and
|
| 4. |
To transact such other business as may properly come before the Annual Meeting.
|
The Board of Directors has fixed the close of business on April 5, 2021, as the record date for determining the stockholders entitled to receive notice of and to vote at the Annual Meeting or
any adjournment or postponement thereof.
|
Attending and Voting at the Annual Meeting
Due to the COVID-19 pandemic, the Annual Meeting will be held virtually, with attendance via live audio webcast. You will not be able to attend the Annual
Meeting in person.
To attend the virtual Annual Meeting, you must pre-register by visiting register.proxypush.com/nus and following the
registration instructions on that website before the meeting begins. You will need to enter the control number that is provided on your proxy card or Notice of Internet Availability of Proxy Materials to be able to pre-register. Upon
pre-registering, you will receive a confirmation email.
Approximately one hour before the Annual Meeting, all those who have pre-registered will receive an email with a unique website link that will allow them to
access and participate in the meeting, including listening to the full webcast, submitting questions, voting and viewing a list of stockholders entitled to vote at the meeting. To view this list of stockholders during the meeting, you will
need to enter your control number. You will also have the opportunity to submit questions during the pre-registration process. We plan to respond to all appropriate questions during the webcast.
Entrance to the Annual Meeting will open 15 minutes before the designated start time. We recommend that you access the meeting website prior to the designated
start time to ensure that you are logged in when the meeting begins. Technical support will be available before and during the virtual Annual Meeting; if you encounter any technical difficulties accessing or participating in the meeting,
please call the technical support number that will be provided in the email that will be sent approximately one hour before the meeting. The pre-registration website will also include an email address for technical support.
|
You are cordially invited to attend the virtual Annual Meeting. However, to ensure your representation at the Annual Meeting, please mark, sign, date and return the accompanying proxy card as
promptly as possible in the enclosed postage-paid envelope, or use the internet or telephone methods that are described on the proxy card. If you attend the virtual Annual Meeting, you may, if you wish, withdraw your proxy and vote at the meeting.
Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to be Held on June 2, 2021: The proxy statement and annual report to
stockholders are available at www.proxydocs.com/NUS.
|
By Order of the Board of Directors,
|
|
 |
|
|
STEVEN J. LUND
|
|
|
Chairman of the Board
|
|
|
Provo, Utah
April 12, 2021
|
 |
|
PROXY SUMMARY
|
The following summary provides quick information for purposes of Nu Skin’s 2021 Annual Meeting. It does not contain all of the information provided elsewhere in the proxy statement; therefore, you should read the
entire proxy statement carefully before voting. This proxy statement and form of proxy are first being sent or given to our stockholders on or about April 21, 2021.
ANNUAL MEETING INFORMATION
|
Date:
|
June 2, 2021
|
|
Time:
|
11:00 a.m., Mountain Daylight Time
|
|
Access:
|
Due to the COVID-19 pandemic, the Annual Meeting will be held virtually, with attendance via live audio webcast. You will not be able to attend the Annual Meeting in person. Details
for accessing the meeting are provided in this proxy statement.
|
|
Record date:
|
April 5, 2021
|
PROPOSALS
|
Proposal
|
Board
Recommendation
|
More
Information
|
|
|
1.
|
Election of the nine directors named in this proxy statement
|
For each director nominee
|
Page 3
|
|
2.
|
Approval of our executive compensation*
|
For
|
Page 47
|
|
3.
|
Ratification of the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2021*
|
For
|
Page 49
|
* Advisory vote
CORPORATE GOVERNANCE AND COMPENSATION HIGHLIGHTS
See pages 8 and 21, respectively.
DIRECTOR NOMINEES
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
Skills and Experience
|
|||||||||
|
Other public company board/exec. experience
|
•
|
•
|
•
|
•
|
•
|
•
|
|||
|
Corporate finance/transactions
|
•
|
•
|
•
|
•
|
•
|
||||
|
International experience/global operations
|
•
|
•
|
•
|
•
|
•
|
•
|
•
|
||
|
Government relations
|
•
|
||||||||
|
Regulatory
|
•
|
•
|
|||||||
|
Risk management
|
•
|
•
|
•
|
•
|
|||||
|
Sales/marketing
|
•
|
•
|
•
|
•
|
•
|
||||
|
Online or digital marketing
|
•
|
•
|
•
|
||||||
|
Strategic planning
|
•
|
•
|
•
|
•
|
•
|
•
|
•
|
||
|
Current Nu Skin Committee Service
|
|||||||||
|
Audit Committee
|
•
|
•
|
•
|
||||||
|
Executive Compensation Committee
|
•
|
•
|
•
|
•
|
|||||
|
Nominating and Corp. Governance Committee
|
•
|
•
|
•
|
•
|
|||||
|
Other Characteristics
|
|||||||||
|
Independence
|
•
|
•
|
•
|
•
|
•
|
•
|
•
|
||
|
Gender diversity
|
•
|
•
|
•
|
||||||
|
Racial/ethnic diversity
|
•
|
•
|
|||||||
|
Age
|
60
|
66
|
69
|
67
|
47
|
63
|
76
|
41
|
69
|
|
Tenure (years)
|
0
|
24
|
22
|
25
|
0
|
2
|
13
|
5
|
6
|
BOARD COMPOSITION
|
Current Directors
|
Director Nominees
|
||
|
Average Tenure
|
13 years
|
11 years
|
|
|
Average Age
|
63
|
62
|
|
| Independence |  |
 |
|
| Committee Independence |  |
|
|
| Gender Diversity |  |
 |
|
| Racial/Ethnic Diversity |  |
 |
|
1
|
||
|
1
|
||
|
3
|
||
|
8
|
||
|
8
|
||
|
9
|
||
|
9
|
||
|
9
|
||
|
10
|
||
|
11
|
||
|
11
|
||
|
12
|
||
|
14
|
||
|
14
|
||
|
14
|
||
|
15
|
||
|
15
|
||
|
16
|
||
|
18
|
||
|
18
|
||
|
22
|
||
|
23
|
||
|
29
|
||
|
31
|
||
|
33
|
||
|
34
|
||
|
45
|
||
|
45
|
||
|
45
|
||
|
47
|
||
|
49
|
||
|
49
|
||
|
50
|
||
|
51
|
||
|
52
|
||
|
53
|
||
|
53
|
||
|
54
|
||
|
55
|
||
|
55
|
||
|
56
|
||
|
56
|
||
|
PROXY STATEMENT
|
The accompanying proxy is solicited on behalf of the Board of Directors of Nu Skin Enterprises, Inc. (“Nu Skin,” “we,” “us,” or “the company”) for use at the Annual Meeting of Stockholders
(the “Annual Meeting”) on June 2, 2021, at 11:00 a.m., Mountain Daylight Time, and at any adjournment or postponement thereof. Due to the COVID-19 pandemic, the Annual Meeting will be held virtually, with attendance via live audio webcast. You will
not be able to attend the Annual Meeting in person.
At the Annual Meeting, you will be asked to consider and vote on the following matters, which are more fully described in this proxy statement:
| 1. |
To elect the nine directors named in this proxy statement;
|
| 2. |
To hold an advisory vote to approve our executive compensation;
|
| 3. |
To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2021; and
|
| 4. |
To transact such other business as may properly come before the Annual Meeting.
|
This proxy statement and form of proxy are first being sent or given to our stockholders on or about April 21, 2021. We will bear the cost of solicitation of proxies. Expenses include
reimbursements paid to brokerage firms and others for their expenses incurred in forwarding solicitation material regarding the Annual Meeting to beneficial owners of our voting stock. Our regular employees may further solicit proxies by telephone,
by mail, in person or by electronic communication and will not receive additional compensation for such solicitation.
VOTING PROVISIONS
Record Date; Shares Outstanding. Only stockholders of record at the close of business on April 5, 2021 are
entitled to vote at the Annual Meeting. As of this record date, 50,134,073 shares of our Class A Common Stock were issued and outstanding. Each outstanding share of Class A Common Stock will be entitled to one vote on each matter submitted to a
vote of the stockholders at the Annual Meeting.
How Proxies Will Be Voted. All shares represented by each properly executed, unrevoked proxy received in time
for the Annual Meeting will be voted as directed by the stockholder. Each stockholder may appoint only one proxy holder or representative to attend the meeting on his or her behalf. In the absence of specific instructions, proxies will be voted in
accordance with the Board of Directors’ recommendations “FOR” the election of each director nominee and “FOR” Proposals 2 and 3. Although it is anticipated that each nominee will be able to serve as a director, should any nominee become unavailable
to serve, proxies will be voted for such other person or persons as may be designated by the Board of Directors. If any other matters properly come before the Annual Meeting, including, among other things, consideration of a motion to adjourn the
Annual Meeting to another time or place, the persons named in the accompanying proxy will vote on such matters in accordance with their best judgment.
Revocability of Proxy. Any proxy duly given pursuant to this solicitation may be revoked by the person or
entity giving it at any time before it is voted by delivering a written notice of revocation to our Corporate Secretary, by executing a later-dated proxy and delivering it to our Corporate Secretary, or by voting at the Annual Meeting (although
attendance at the Annual Meeting will not in and of itself constitute a revocation of the proxy). If you hold shares through a broker, bank or other nominee, you must follow the instructions of your broker, bank or other nominee to change or revoke
your voting instructions
Attending and Voting at the Annual Meeting. To attend the virtual Annual Meeting, you must pre-register by
visiting register.proxypush.com/nus and following the registration instructions on that website before the meeting begins. You will
need to enter the control number that is provided on your proxy card or Notice of Internet Availability of Proxy Materials to be able to pre-register. Upon pre-registering, you will receive a confirmation email.
Approximately one hour before the Annual Meeting, all those who have pre-registered will receive an email with a unique website link that will allow them to access and participate in the
meeting, including listening to the full webcast, submitting questions, voting and viewing a list of stockholders entitled to vote at the meeting. To view this list of stockholders during the meeting, you will need to enter your control number. You
will also have the opportunity to submit questions during the pre-registration process. We plan to respond to all appropriate questions during the webcast.
Entrance to the Annual Meeting will open 15 minutes before the designated start time. We recommend that you access the meeting website prior to the designated start time to ensure that you
are logged in when the meeting begins. Technical support will be available before and during the virtual Annual Meeting; if you encounter any technical difficulties accessing or participating in the meeting, please call the technical support number
that will be provided in the email that will be sent approximately one hour before the meeting. The pre-registration website will also include an email address for technical support.
Please note that recording the Annual Meeting will not be permitted.
Quorum. In order to constitute a quorum for the conduct of business at the Annual Meeting, a majority of the
issued and outstanding shares of the Class A Common Stock entitled to vote at the Annual Meeting must be represented, either in person or by proxy, at the Annual Meeting. Under Delaware law, shares represented by proxy that reflect abstentions or
“broker non-votes” (which are shares held by a broker or nominee that are represented at the Annual Meeting, but with respect to which such broker or nominee is not permitted to vote on a particular proposal without instructions from the beneficial
owner and instructions are not given) will be counted as shares that are present and entitled to vote for purposes of determining the presence of a quorum. However, broker non-votes will not be voted on proposals on which your broker or other
nominee does not have discretionary authority to vote under the rules of the New York Stock Exchange (the “NYSE”), including Proposals 1 and 2.
Voting Standards and Effects. Pursuant to our Bylaws, for a director nominee to be elected or for a proposal
to be approved, such director nominee or proposal must receive more “for” votes than “against” votes. Shares not represented in person or by proxy at the Annual Meeting, abstentions and broker non-votes will have no effect on the determination of
any of the proposals. Additional provisions applying to the matters to be acted upon at the Annual Meeting are as follows:
| − |
Proposal 1. If an incumbent director does not receive the required majority, the director shall resign pursuant to an irrevocable resignation that was
required to be tendered prior to his or her nomination and effective upon (i) such person failing to receive the required majority vote and (ii) the Board’s acceptance of such resignation. Within 90 days after the date of the certification
of the election results, the Board will determine whether to accept or reject the resignation or whether other action should be taken, and the Board will publicly disclose its decision.
|
| − |
Proposals 2 and 3. Proposals 2 and 3 are stockholder advisory votes and will not be binding on the Board of Directors.
|
ELECTION OF DIRECTORS
Directors are elected at each annual meeting of stockholders and hold office until their successors are duly elected and qualified at the next annual meeting of stockholders or until their
earlier death, resignation or removal. Our Bylaws provide that the Board of Directors will consist of a minimum of three and a maximum of fifteen directors, with the number being designated by the Board. The current number of authorized directors is
eight, but it will increase to nine at the time of the director elections at the Annual Meeting.
Set forth below are the name, age as of April 1, 2021, business experience and other qualifications of each of our nine director nominees, listed in alphabetical order. Each of the nominees
is a current director and was elected at our 2020 annual meeting of stockholders, except for Emma S. Battle and Ryan S. Napierski. Ms. Battle was recommended by Edwina D. Woodbury, one of our independent directors. We are not aware of any family
relationships among any of our directors, director nominees or executive officers.
As previously disclosed, in February 2021, Ritch N. Wood notified our Board that he will step down as our Chief Executive Officer, effective September 1, 2021, and will therefore not stand
for reelection to the Board at the Annual Meeting. Our Board extends gratitude to Mr. Wood for his many years of service to our company in several roles, including Chief Executive Officer, Chief Financial Officer and a member of our Board. Upon Mr.
Wood's retirement, Mr. Napierski will become our Chief Executive Officer.
|
Emma S. Battle
|
|
|
Director nominee
|
|
|
Emma S. Battle, 60, has served as the President and Chief Executive Officer of Market Vigor, LLC, a business services company focused on strategic consulting and digital and online
marketing, since she founded the company in 2003. From 2015 to 2017, Ms. Battle was Vice President of Client Success at Windsor Circle, an e-commerce marketing company. Previously, she served in executive and senior marketing and sales roles
at Three Ships Media, Red Hat, Art.com, 1 Sync and Sara Lee Branded Apparel (now known as Hanesbrands Inc.). Ms. Battle has served on the board of directors of Unifi, Inc., a global textile solutions provider listed on the NYSE, since January
2021 and of Bassett Furniture Industries, Inc., a manufacturer and marketer of home furnishings listed on the Nasdaq Global Select Market, since October 2020. From 2019 to 2020, she was on the board of directors of Primo Water Corporation, a
provider of drinking water products that was listed on the Nasdaq Global Market until the company was acquired in 2020. Ms. Battle pursues continuing education through online classes and membership in professional organizations like Brentwood
Advisory Group, and supports and collaborates with current and aspiring board directors through UNC's Director Diversity Initiative, Onboard NC, Santa Clara University's Black Corporate Board Readiness program and the newly established Take
Your Seat initiative. Ms. Battle also devotes time to charitable and civic causes; since 2017 she has served as the President and Chief Executive Officer of Higher Ed Works, a charitable organization that supports public higher education in
North Carolina, and she also serves on the boards of FPG Child Development Institute, Southeastern Wind Coalition, and Elon University's School of Business. She received a B.A. degree from Duke University and a M.B.A. degree from Harvard
Business School.
Ms. Battle is a successful businessperson with an extensive background in digital and online marketing, marketing analytics, and business and marketing strategy, which the Board
believes will be valuable as we continue to build our digital business. She also brings to the Board her perspective from working with other large corporations and on other public company boards. In addition, the Board believes that her
experience managing and consulting with smaller, entrepreneurial businesses will provide a valuable perspective in managing our business in a manner that is effective for our independent sales force. The Board also values Ms. Battle’s
commitment to sustainability and social responsibility, which are two areas of focus for our company and many stockholders.
|
|
Daniel W. Campbell
|
|
|
Director since 1997
|
Lead Independent Director
|
|
Audit Committee
|
|
|
Executive Compensation Committee
|
|
|
Daniel W. Campbell, 66, has been a Managing General Partner of EsNet, Ltd., a privately held investment company, since 1994. He served on the Utah State Board of Regents for Higher
Education from 2010 to 2019, having served as its Vice Chair from 2012 to 2014 and as Chair from 2014 to 2018. From 1992 to 1994, Mr. Campbell was the Senior Vice President and Chief Financial Officer of WordPerfect Corporation, a software
company, and prior to that was a partner of Price Waterhouse LLP. He received a B.S. degree from Brigham Young University.
Mr. Campbell is a recognized business leader with expertise in the areas of finance, accounting, transactions, corporate governance and management. He has served on the boards of
several other private and public companies. In addition, through his experience as a partner of an international accounting firm, and later as Chief Financial Officer of a large technology company, Mr. Campbell has developed deep insight into
the management, operations, finances and governance of public companies.
|
|
Andrew D. Lipman
|
|
|
Director since 1999
|
Executive Compensation Committee
|
|
Nominating and Corporate Governance Committee (Chair)
|
|
|
Andrew D. Lipman, 69, is a partner and head of the Telecommunications, Media and Technology Group at Morgan, Lewis & Bockius LLP, an international law firm that he
joined in 2014. He previously held similar positions with Bingham McCutchen LLP from 2006 to 2014 and Swidler Berlin LLP from 1988 to 2006. From 2000 to 2013, Mr. Lipman served as a member of the board of directors of The Management Network
Group, Inc., a telecommunications related consulting firm, and from 2005 to 2013, he served as a member of the board of directors of Sutron Corporation, a provider of hydrological and meteorological monitoring products. He received a B.A.
degree from the University of Rochester and a J.D. degree from Stanford Law School.
Mr. Lipman is a highly experienced senior lawyer and business advisor with over 40 years of experience dealing with international regulatory, technology and marketing issues in
multiple countries. In addition, he has extensive experience in corporate governance and related legal and transactional issues. Mr. Lipman has worked closely with dozens of public companies, including service on the boards of a variety of
companies in several industries. His experience also includes managing and implementing strategic initiatives and launching new products and markets globally in competitive industries.
|
|
Steven J. Lund
|
|
|
Director since 1996
(includes three-year leave
of absence)
|
Executive Chairman of the Board
|
|
Steven J. Lund, 67, has served as the Chairman of the Board since 2012. Mr. Lund previously served as Vice Chairman of the Board from 2006 to 2012. Mr. Lund served as President, Chief
Executive Officer and a director of our company from 1996, when our company went public, until 2003, when he took a three-year leave of absence. Mr. Lund was a founding stockholder of our company. Mr. Lund is a trustee of the Force for Good
Foundation, a charitable organization that our company established in 1996 to help encourage and drive the philanthropic efforts of our company, its employees, its sales force and its customers to enrich the lives of others. Mr. Lund worked
as an attorney in private practice prior to joining our company as Vice President and General Counsel. He received a B.A. degree from Brigham Young University and a J.D. degree from Brigham Young University’s J. Reuben Clark Law School.
Mr. Lund brings to the Board over 35 years of company and industry knowledge and experience as a senior executive, including service as our General Counsel, Executive Vice President,
and President and Chief Executive Officer. He played an integral role in managing our growth from start-up through his term as President and Chief Executive Officer. Mr. Lund also served on the Executive Board of the United States Direct
Selling Association. A respected leader in his business, religious and civic communities, he currently serves as a general officer of The Church of Jesus Christ of Latter-day Saints and serves on this Church's Board of Education with
oversight of its institutions of higher education, including Brigham Young University. He previously served on the Utah State Board of Regents for Higher Education and as Chairman of the Board of Trustees of Utah Valley University.
|
|
Ryan S. Napierski
|
|
|
Director nominee
|
|
|
Ryan S. Napierski, 47, has served as our company’s President since 2017. Previously, he served as President of Global Sales and Operations from 2015 to 2017. Prior to serving in that
position, he served as both President of our North Asia region since 2014 and President of Nu Skin Japan since 2010. Mr. Napierski has fulfilled multiple leadership positions for Nu Skin since joining our company in 1995, including Vice
President of Business Development for Nu Skin EMEA and General Manager of the United Kingdom. Mr. Napierski has a Bachelor’s degree in business, a Master's degree in business administration from Duke University and a Master's degree in
international business from Goethe Universitat in Germany.
Mr. Napierski brings to the Board a strong expertise in direct sales, including through digital and social media platforms. With his service as our President, President of Global
Sales and Operations, and other management roles in our markets, Mr. Napierski also has a deep understanding of our business globally, including our sales force, products and product development, markets and compensation plans. Mr.
Napierski’s leadership has been integral to the success of several of our key initiatives in recent years. Mr. Napierski is also recognized as a leader in the direct selling industry and has served in a variety of industry trade association
leadership roles; he currently serves as both Chairman of the United States Direct Selling Association and Chairman of the Advocacy Committee for the World Federation of Direct Selling Associations.
|
|
Laura Nathanson
|
|
|
Director since 2019
|
Executive Compensation Committee
|
|
Nominating and Corporate Governance Committee
|
|
|
Thomas R. Pisano
|
|
|
Audit Committee
|
|
|
Executive Compensation Committee (Chair)
|
|
|
Thomas R. Pisano, 76, served as Chief Executive Officer and a director of Overseas Military Sales Corp. ("OMSC"), a marketer of motor vehicles, from 2005 until his retirement in 2010. From 1998
to 2004, he served as the Chief Operating Officer and a director of OMSC From 1995 to 1997, he served as Vice President and Head of the International Division for The Topps Company, Inc., a sports publications and confectionery products
company. Prior to that, he served in various positions, including Vice President of Global New Business Development, for Avon Products, Inc., a direct seller of personal care products, from 1969 to 1994. He received a B.S. from the Georgia
Institute of Technology and a M.B.A. from Dartmouth College.
Mr. Pisano is an experienced senior executive who is an expert in the direct selling, personal care, beauty products and other consumer goods industries. During his 25-year career at Avon, he
was responsible for global new business development, which included new geographic market openings and launching new product lines globally. He was also responsible for the operation of international businesses in Latin America, Europe and
Asia. During his international business career at Avon, Topps and OMSC, he traveled to and conducted business in 50 countries.
|
|
Zheqing (Simon) Shen
|
|
|
Director since 2016
|
Nominating and Corporate Governance Committee
|
|
Edwina D. Woodbury
|
|
|
Director since 2015
|
Audit Committee (Chair)
|
|
Nominating and Corporate Governance Committee
|
|
|
Edwina D. Woodbury, 69, has been President and Chief Executive Officer of The Chapel Hill Press, Inc., a publishing services company, since 1999. Ms. Woodbury has over 20 years of experience in
the direct selling and personal care products industries, having served at Avon Products, Inc. as Chief Financial and Administrative Officer and in other finance and operations positions from 1977 to 1998. From 1998 to 2015, Ms. Woodbury
served as a member of the board of directors of RadioShack Corporation, a retail consumer electronics company. In addition, from 2005 to 2010, Ms. Woodbury served as a member of the board of directors of R.H. Donnelley Corporation, a
publishing and marketing company, and from 2000 to 2005, she served as a director of Click Commerce, Inc., a research solutions company. Ms. Woodbury also served on the board of directors at the nonprofit Medical Foundation of North Carolina
from 2009 to 2018. She received a B.S.B.A from the University of North Carolina.
Ms. Woodbury has extensive experience and understanding of our industry. While serving in various roles of increasing responsibility during her 21 years at Avon, she gained an in-depth
understanding of the financial and internal control-related issues associated with global companies in our industry. She also brings to the Board valuable perspective from her service on other public company boards. While serving on the
boards at Click Commerce, R.H. Donnelley and RadioShack, she (1) served on and chaired each board’s audit committee; (2) served on the compensation committee at R.H. Donnelley and chaired it at RadioShack; and (3) served on the nominating and
governance committee at Click Commerce and RadioShack.
|
———————————————
Each nominee was recommended by the Nominating and Corporate Governance Committee for election and has consented to being named in this proxy statement and to serve if elected. Although we do not know of any reason for
which any nominee might become unavailable to serve on the Board, if that should happen, the Board may designate a substitute nominee. Shares represented by proxies will be voted for any substitute nominee so designated.
THE BOARD OF DIRECTORS RECOMMENDS THAT STOCKHOLDERS VOTE “FOR” EACH OF THE NINE NOMINEES TO OUR BOARD OF DIRECTORS.
Board of Directors Independence and Committee Structure
| − |
Separate Chairman of the Board and CEO. The positions of Chairman of the Board and CEO are filled by Mr. Lund and Mr. Wood, respectively.
|
| − |
Lead Independent Director. Our independent directors have designated Mr. Campbell as Lead Independent Director.
|
| − |
Limitation on Management Directors. All of our current directors are independent of the company and management except for Mr. Lund, who is one of our
company’s founders, and Mr. Wood, our CEO. If elected, Mr. Napierski will not be independent.
|
| − |
Meetings of Independent Directors. All independent directors meet regularly in executive session. Mr. Campbell, the Lead Independent Director, chairs
these sessions.
|
| − |
Independent Committees. Only independent directors serve on our Audit, Executive Compensation, and Nominating and Corporate Governance Committees.
|
| − |
Annual Board and Committee Performance Evaluations. The performance of the Board and each Board committee is evaluated at least annually.
|
Election of Directors
| − |
Annual Election of Directors. All of our directors are elected annually; we do not have a staggered board.
|
| − |
Majority Voting in Uncontested Director Elections and Resignation Policy. Our Bylaws provide that director nominees must be elected by a majority of the
votes cast in uncontested elections. For an incumbent director to be nominated for re-election, she or he must tender an irrevocable resignation that will be effective upon (i) the failure to receive the required vote for director election
at the next annual meeting at which they face re-election and (ii) Board acceptance of such resignation.
|
Stock-Related Matters
| − |
Equity Retention Requirements. We have equity retention requirements that apply to our directors and executive officers, designed to align directors’
and executive officers’ interests with those of stockholders. For a description of these requirements, see “Executive Compensation: Compensation Discussion and Analysis—Equity Retention Guidelines.”
|
| − |
Hedging Policy. Our directors and employees, including officers, are prohibited from engaging in any hedging transactions with respect to our
securities, including through the use of short sales, put options and financial instruments such as prepaid variable forward contracts, equity swaps, collars and exchange funds. This prohibition applies regardless of whether the director’s
or employee’s securities were granted as compensation and regardless of whether the director or employee holds the securities directly or indirectly.
|
| − |
Pledging Policy. Our directors and employees, including officers, are prohibited from pledging their securities in our company.
|
The Board of Directors has determined that each of the current directors listed below is an “independent director” under the listing standards of the NYSE.
|
Daniel W. Campbell
|
Andrew D. Lipman
|
Laura Nathanson
|
|
Thomas R. Pisano
|
Zheqing (Simon) Shen
|
Edwina D. Woodbury
|
The Board also has determined that Emma S. Battle, who is a nominee not currently on the Board, will be an “independent director” under the listing standards of the NYSE if elected.
In assessing the independence of the directors, the Board determines whether or not any director has a material relationship with us (either directly or as a partner, stockholder or officer of an
organization that has a relationship with us). The Board considers all relevant facts and circumstances in making independence determinations, including the existence and scope of any commercial, industrial, banking, consulting, legal, accounting,
charitable and familial relationships.
We currently separate the roles of Chairman of the Board and CEO. However, the Board has not adopted a policy with regard to whether the same person should serve as both the Chairman of the Board and
CEO or, if the roles are separate, whether the Chairman of the Board should be selected from the non-employee directors or should be an employee. The Board believes it is most appropriate to retain the discretion and flexibility to make such
determinations at any given point in time in the way that it believes best to provide appropriate leadership for the company at that time. We have determined that our current separation of the roles of Chairman of the Board and CEO is appropriate
given the differences in the roles and duties of the two positions and the individuals currently serving in these positions.
The Board has created the Lead Independent Director position to provide independent leadership of the Board’s affairs on behalf of our stockholders and to promote open communication among the
independent directors. Our Corporate Governance Guidelines provide that the Lead Independent Director (i) is designated by the non-management directors; (ii) consults with the Chairman of the Board and the CEO regarding agenda items for Board
meetings; (iii) chairs executive sessions of the Board’s independent directors; and (iv) performs such other duties as the Board deems appropriate.
Our Board of Directors has primary responsibility for risk oversight. Except with regard to certain strategically significant risks, the Board administers its risk oversight function through the Audit
Committee, Nominating and Corporate Governance Committee and Executive Compensation Committee. The committee charters include the following subject-matter parameters for risk oversight:
|
Audit Committee
|
Nominating and Corporate
Governance Committee
|
Executive Compensation
Committee
|
|||
| - |
Major financial risk exposures
|
- |
Corporate governance risks
|
- |
Compensation practices related risks
|
| - |
Operational risks related to information systems and facilities
|
- |
Operational risks not assigned to the Audit Committee
|
- |
Human resources risks
|
| - |
Public disclosure and investor related risks
|
- |
Compliance and regulatory risks
|
||
| - |
Reputational risks
|
||||
The committees, or the Board in the case of risks it determines to oversee directly, are responsible for overseeing and discussing with management our risk assessment and risk management programs and
plans. Management periodically reports to the Board or applicable committee on our risks and the internal processes, practices and controls attendant to the risks. Following these reports by management, the Audit Committee periodically receives
reports regarding the Nominating and Corporate Governance Committee’s and Executive Compensation Committee’s risk-oversight efforts.
Our Board directly oversees cyber and privacy-related risks and periodically receives reports from management on these risks. Because the Board and management recognize the importance of maintaining the
trust and confidence of our employees, sales force, customers, vendors and other business partners, we have established an Information Security and Privacy group that has responsibility for executing a program to protect our data. This group
identifies, tracks, and monitors risks in this area, and they follow standardized cybersecurity frameworks, including CIS and NIST-CSF, in measuring our security risks. We also have implemented a training program: all employees receive annual
training, which is translated into multiple languages, and employees in elevated roles participate in more-frequent monthly training sessions. We also conduct unannounced phishing simulation exercises to help our employees remain vigilant against
cybersecurity threats.
Our Board’s committees engage with our senior management and head of Human Resources regarding human capital management on a regular basis. Working with management, our Board’s committees oversee and
receive reports on matters including culture, compensation, benefits, key talent succession planning, employee engagement, and diversity, equity and inclusion. Each year, our management also reports to the Executive Compensation Committee on
management’s annual assessment of risks related to our compensation policies and practices. In addition, our Nominating and Corporate Governance Committee conducts annual performance reviews for our key executive officers, and these performance
reviews include their performance on human capital management initiatives.
All employees are responsible for upholding the Nu Skin Code of Conduct and for striving to perpetuate the Nu Skin Way, our global culture aspiration, which includes the following principles:
|
− A force for good
− Accountable and empowered
− Bold innovators
− Customer obsessed
|
− Direct and decisive
− Exceptional
− Fast speed
− One global team
|
The Nu Skin Way forms the foundation of our human capital strategy and objectives. The three primary objectives of our human capital strategy are:
| 1. |
Support the transformation of our business and culture to align with our business strategies and the Nu Skin Way;
|
| 2. |
Leverage global diversity and build inclusion; and
|
| 3. |
Simplify the employee experience through global alignment and optimization.
|
To measure our progress in achieving these objectives, we conduct a quarterly global employee survey, which also gathers employee feedback for purposes of designing our talent programs, rewards and
benefits. Averaging an approximately 90% response rate during 2020, this survey generates valuable information for us to analyze and to act upon when appropriate. This survey yielded more than 60,000 data points each quarter, consisting of employee
responses to each survey question. We also conducted focus groups with our employees to gather their feedback on the employee experience, including diversity, equity and inclusion matters.
We regularly review our employees' feedback to better align our human capital initiatives to the needs of our employees. For example, after receiving employee feedback that pointed toward a need to
establish a more comprehensive diversity, equity and inclusion strategy, we hired a global head of diversity and inclusion and began conducting a periodic "Listen and Learn" series of employee panels to bring our workforce into a more inclusive
experience. These and other diversity-related initiatives have helped us to achieve employee engagement scores in the top quintile of global companies of a similar size.
Evidencing the success of our human capital management initiatives, in 2020 we were recognized by the Direct Selling News as one of the best places to work in
direct selling, the fifth consecutive year we have received this honor.
Our Board and senior management are engaged in our sustainability initiatives, and we endeavor to integrate sustainability-related risks and opportunities into our business strategy and operations. Our
sustainability team reports annually to our Board and quarterly to our senior management. Focusing on three key areas—product, planet and people—some of our sustainability initiatives are as follows:
|
−
|
Assess, score and improve the environmental impact score of all of our products by 2023 | |
| − |
Change all of our packaging to be recycled, recyclable, reusable, reduced or renewable by 2030 | |
|
Planet
|
−
|
Reduce waste at our facilities through programs that encourage reducing, reusing and recycling, as well as initiatives to reduce electricity usage |
|
People
|
−
|
Invest at least 50% of our Force for Good Foundation’s giving in communities and people that are providing essential resources to our planet and its inhabitants |
Our 2020 sustainability accomplishments include the following:
| − |
Completing our previously announced goal of assessing, scoring and improving the environmental impact score of our top 20 products, as identified when we set this goal during 2019, saving an estimated 16.5 tons of
paper and 21 tons of plastic during 2020;
|
| − |
Offering new bottles for our Nutricentials® line made from 100% post-consumer recycled plastic and tubes made from approximately 34% post-consumer recycled plastic;
|
| − |
Reducing by 70% the packaging materials for our Epoch® Baobab Body Butter by switching the packaging from jars to an environmentally friendly tube;
|
| − |
Winning nine sustainability awards for clean beauty products, sustainable sales leader efforts, and waste and packaging reductions; and
|
| − |
Helping build the Utah Sustainable Business Coalition as a founding member.
|
The Board of Directors held eight meetings during 2020. Each director attended more than 75% of the total Board and respective committee meetings for the period in which they served during 2020.
Although we encourage Board members to attend our annual meetings of stockholders, we do not have a formal policy regarding director attendance at annual stockholder meetings. All eight of our directors who were in office at the time of our 2020
annual meeting of stockholders attended that meeting.
At our 2020 annual meeting of stockholders, the proposal to re-elect Mr. Shen to our Board was approved by 68% of the votes cast "for" and "against." We understand that many of the "against" votes were
due to Mr. Shen's 2019 Board and committee meeting attendance being 73%, which is below the 75% threshold required by many of our investors' voting policies. Mr. Shen lives in Hong Kong, and although he attended all regularly scheduled meetings
during 2019, he was unable to attend three special meetings that had not been on the planned meeting calendar set out for 2019 Board service. In all three cases, time zone differences and prior commitments prevented him from attending.
Our Board agrees that attendance is important. In response to the vote at our 2020 annual meeting, our Board took action to ensure it could serve the best interests of our stockholders, uphold its high
standards of director responsibility and address the underlying reasons for the 2020 election result. In particular, our Board and committees have made it a higher priority to schedule meetings at times that are more compatible with the Hong Kong
time zone, and have actually scheduled an increased proportion of meetings at such times. Mr. Shen informed us during 2020 that he plans to have at least 75% attendance going forward, and his 2020 attendance and 2021 attendance to date have exceeded
that level.
Our Board continues to view Mr. Shen as a strong and valuable Board member. His knowledge of Mainland China, our largest market, and his depth of experience with financial and investment matters are
very beneficial to the Board. In nominating Mr. Shen for re-election at our Annual Meeting, our Board specifically considered Mr. Shen's attendance and the 2020 election results and determined that re-nominating him is in the best interests of our
stockholders due to the value he adds to the Board.
We have standing Audit, Executive Compensation, and Nominating and Corporate Governance Committees. Each member of the committees is independent within the meaning of the listing standards of the NYSE.
In addition, the Audit Committee and the Executive Compensation Committee are composed solely of directors who meet additional, heightened independence standards applicable to members of these committees under the NYSE listing standards and rules of
the Securities and Exchange Commission ("SEC").
The following table identifies the current membership of the committees and states the number of committee meetings held during 2020.
|
Director
|
Audit
|
Executive
Compensation
|
Nominating and
Corporate Governance
|
|
Daniel W. Campbell
|
✔
|
✔
|
|
|
Andrew D. Lipman
|
✔
|
Chair
|
|
|
Laura Nathanson
|
✔
|
✔
|
|
|
Thomas R. Pisano
|
✔
|
Chair
|
|
|
Zheqing (Simon) Shen
|
✔
|
||
|
Edwina Woodbury
|
Chair
|
✔
|
|
|
2020 Meetings
|
15
|
12
|
12
|
The Board has adopted a written charter for each of the committees, which are available in the “Corporate Governance” section of our Investor Relations website at ir.nuskin.com.
Audit Committee
The Audit Committee’s responsibilities include, among other things:
| − |
Selecting our independent auditor;
|
| − |
Overseeing the performance of our internal audit function and independent auditor;
|
| − |
Reviewing the activities and the reports of our independent auditor;
|
| − |
Approving in advance the audit and non-audit services provided by our independent auditor;
|
| − |
Reviewing our quarterly and annual financial statements and our significant accounting policies, practices and procedures;
|
| − |
Reviewing the adequacy of our internal controls and internal auditing methods and procedures;
|
| − |
Overseeing our compliance with legal and regulatory requirements;
|
| − |
Overseeing our risk assessment and risk management programs and plans related to our major financial risk exposures, operational risks related to information systems and facilities, and public disclosure and
investor related risks; and
|
| − |
Conferring with the chairs of the Nominating and Corporate Governance Committee and Executive Compensation Committee regarding their respective oversight of our risk assessment and risk management programs and our
related guidelines and policies.
|
The Board has determined that Ms. Woodbury and Mr. Campbell are Audit Committee financial experts as such term is defined in Item 407(d)(5) of Regulation S-K promulgated by the SEC.
Executive Compensation Committee
The Executive Compensation Committee’s responsibilities include, among other things:
| − |
Establishing and administering our executive compensation strategy, policies and practices;
|
| − |
Reviewing and approving corporate goals and objectives relevant to the compensation to be paid to our CEO, Executive Chairman of the Board and other executive officers, evaluating the performance of these
individuals in light of those goals and objectives, and determining and approving the forms and levels of compensation based on this evaluation;
|
| − |
Administering our equity incentive plans;
|
| − |
Overseeing our risk assessment and risk management programs and plans related to our compensation practices and human resources; and
|
| − |
Overseeing the reporting of executive compensation information in accordance with applicable rules and regulations.
|
Pursuant to its charter, the Executive Compensation Committee may delegate its authority to a subcommittee or subcommittees and may delegate authority to the CEO and Chairman of the Board to approve the
level of incentive awards to be granted to specific non-executive officers, employees or other grantees subject to such limitations as may be established by the Executive Compensation Committee. For a discussion of the processes and procedures for
determining executive and director compensation and the role of compensation consultants in determining or recommending the amount or form of compensation, see “Executive Compensation: Compensation Discussion and Analysis” and “Director
Compensation.”
Nominating and Corporate Governance Committee
The Nominating and Corporate Governance Committee’s responsibilities include, among other things:
| − |
Making recommendations to the Board of Directors about the size and membership criteria of the Board or any committee thereof;
|
| − |
Identifying and recommending candidates for the Board and committee membership, including evaluating director nominations received from stockholders;
|
| − |
Annually reviewing CEO succession planning as well as succession planning and management development for other executive officer positions;
|
| − |
Leading the process of identifying and screening candidates for a new CEO when necessary, and evaluating the performance of the CEO and Executive Chairman;
|
| − |
Making recommendations to the Board regarding changes in compensation of non-employee directors and overseeing the evaluation of the Board and management;
|
| − |
Developing and recommending to the Board a set of corporate governance guidelines and reviewing such guidelines at least annually;
|
| − |
Overseeing our risk assessment and risk management programs and plans related to our corporate governance risks, operational risks not assigned to the Audit Committee, compliance and regulatory risks, and
reputational risks; and
|
| − |
Overseeing our regulatory, legal and compliance obligations in the foreign countries in which we operate, as well as individual compliance programs developed to address specific legal and regulatory issues in the
United States and foreign countries.
|
Our Board believes that a strong and constructive evaluation process is an important component of good corporate governance and helps to promote Board effectiveness. Our annual evaluation process, which
is led by our Nominating and Corporate Governance Committee, focuses on both the Board and the Board committees.
The Nominating and Corporate Governance Committee reviews the format of our evaluation process each year to ensure that it remains robust and relevant. In 2020, we used a third-party facilitator to
assist in conducting the evaluation in order to receive fresh perspectives on Board effectiveness and corporate governance practices and to encourage candor in the evaluation process. The facilitator collected feedback from each director and then led
a discussion at an in-person meeting.
None of the directors who served on the Executive Compensation Committee during 2020 was:
| − |
A current or former officer or employee of our company;
|
| − |
A participant during 2020 in a related-person transaction that is required to be disclosed; or
|
| − |
An executive officer of another entity at which one of our executive officers served during 2020 on either the board of directors or the compensation committee, nor were any of our other directors an executive
officer of another entity at which one of our executive officers served on the compensation committee.
|
As indicated above, the Nominating and Corporate Governance Committee of the Board of Directors oversees the director nomination process. This committee is responsible for identifying and evaluating
candidates for membership on the Board and recommending to the Board nominees to stand for election.
Minimum Criteria for Members of the Board. Each candidate to serve on the Board must possess the highest personal and professional
ethics, integrity and values, and be committed to serving the long-term interests of our stockholders. In addition, our Corporate Governance Guidelines require that, to be nominated for re-election to our Board, an incumbent director must tender an
irrevocable resignation that will be effective upon (i) the failure to receive the required vote for director election at the next annual meeting at which they face re-election and (ii) Board acceptance of such resignation. Other than the
foregoing, there are no stated minimum criteria for director nominees, although the Nominating and Corporate Governance Committee may consider such other factors as it may deem appropriate, which may include, without limitation, professional
experience; diversity of backgrounds, skills and experience at policy-making levels in business, government, financial, and other areas relevant to our global operations; experience and history with our company; and stock ownership.
We do not have a formal policy regarding the consideration of diversity in identifying Board nominees. However, our Board and our Nominating and Corporate Governance Committee believe that diversity is
an important consideration in Board composition, as men and women of different skills, areas of expertise and experience, races, and ethnic backgrounds can contribute different and useful perspectives to help the Board, as a group, to more
effectively oversee our business.
Process for Identifying, Evaluating and Recommending Candidates. The Nominating and Corporate Governance Committee will consider
director candidates recommended by stockholders if properly submitted to the committee. Stockholders wishing to recommend candidates should do so in writing to the Nominating and Corporate Governance Committee, c/o Corporate Secretary, Nu Skin
Enterprises, Inc., 75 West Center Street, Provo, Utah 84601. The committee may also consider candidates proposed by current directors, management, employees and others. All such candidates who, after evaluation, are then recommended by the
Nominating and Corporate Governance Committee and approved by the Board will be included in our recommended slate of director nominees in our proxy statement.
Procedures for Stockholders to Nominate Director Candidates at our Annual Meetings. Stockholders of record may also nominate
director candidates for our annual meetings of stockholders by following the procedures set forth in our Bylaws. Please refer to the section below titled “Stockholder Proposals for 2022 Annual Meeting” for further information.
Stockholders or other interested parties wishing to communicate with the Board of Directors, the non-management directors as a group, the Lead
Independent Director or any other individual director may do so in writing by addressing the correspondence to that individual or group, c/o Corporate Secretary, Nu Skin Enterprises, Inc., 75 West Center Street, Provo, Utah 84601. All such
communications will be initially received and processed by our Corporate Secretary. Accounting, audit, internal accounting controls and other financial matters will be referred to our Audit Committee chair. Other matters will be referred to the
Board, the non-management directors, or individual directors as appropriate.
We have adopted the following:
| − |
Code of Conduct. Our code of conduct applies to all of our employees, officers and directors, including our subsidiaries. Any amendments or waivers
(including implicit waivers) regarding the Code of Conduct requiring disclosure under applicable SEC rules or NYSE listing standards will be disclosed in the “Corporate Governance” section of our Investor Relations website at ir.nuskin.com.
|
| − |
Corporate Governance Guidelines. Our corporate governance guidelines govern our company and our Board of Directors on matters of corporate governance,
including responsibilities, committees of the Board and their charters, director independence, director qualifications, director compensation and evaluations, director orientation and education, director access to management, director
access to outside financial, business and legal advisors and management development and succession planning.
|
Both of the above are available in the “Corporate Governance” section of our Investor Relations website at ir.nuskin.com. In addition, stockholders may obtain a
print copy of either of the above, free of charge, by making a written request to Investor Relations, Nu Skin Enterprises, Inc., 75 West Center Street, Provo, Utah 84601.
Our Nominating and Corporate Governance Committee is responsible for evaluating director compensation from time to time, and when it determines that adjustments are appropriate, it recommends them to
the Board of Directors for its consideration. The Nominating and Corporate Governance Committee has retained the services of Semler Brossy Consulting Group LLC as its independent compensation consultant to assist in the review of our director
compensation program, to provide compensation data and alternatives, and to provide advice as requested. For additional information regarding our independent compensation consultant, see “Executive Compensation: Compensation Discussion and
Analysis—Role of Compensation Consultant.”
The following table summarizes our non-employee director compensation program, which applies to each director besides Messrs. Lund and Wood because they receive compensation as executive officers of our
company. The table shows the program as in effect during 2020 and the changes that were approved in early 2021 following the review of our director compensation program and will take effect as of June 1, 2021. The increases in retainers for
leadership positions aim to more closely align with market practice. The increase in the annual equity award aims to better compensate the directors for an increased workload, particularly at the committee level, in a manner that maintains alignment
with stockholder interests.
|
2020 Program
|
Changes Approved in
2021
|
|||||
|
Annual cash retainer
Board
Committee
|
$85,000
$10,000 per committee
|
Unchanged
|
||||
|
Additional annual cash retainer for leadership:
Lead Independent Director
Audit Committee Chair
Other committee chairs
|
$20,000
$15,000
$10,000
|
$25,000
$20,000
$15,000
|
||||
|
Meeting fees
|
None(1)
|
Unchanged
|
||||
|
Annual equity award (restricted stock units)
|
$140,000 value
|
$150,000 value
|
| (1) |
The Board can approve meeting fees for participation in a special committee or other extraordinary circumstances.
|
In addition, we may compensate a director $1,500 per day for corporate events or travel that we require, and we may reimburse directors for certain expenses incurred in attending Board and committee
meetings and other corporate events. We also provide company products to our directors for their use.
Pursuant to the terms of our Third Amended and Restated 2010 Omnibus Incentive Plan, the cash compensation and the aggregate grant date fair value (computed in accordance with applicable financial
accounting rules) of awards under the Plan provided to any non-employee director during any single calendar year cannot exceed $750,000.
Director Compensation Table – 2020
The table below summarizes the compensation earned by or paid to each of our directors in 2020 except Mr. Wood, whose compensation is reported in the executive compensation tables. Mr. Wood serves as a
director, but as a company employee he receives no compensation for his services as a director.
|
Name
|
Fees Earned or
Paid in Cash ($)
|
Stock
Awards
($)(1)
|
All Other
Compensation
($)(2)
|
Total ($)
|
|
Daniel W. Campbell
|
125,000
|
135,920
|
—
|
260,920
|
|
Andrew D. Lipman
|
130,000
|
135,920
|
—
|
265,920
|
|
Laura Nathanson
|
114,000
|
135,920
|
—
|
249,920
|
|
Thomas R. Pisano
|
124,000
|
135,920
|
—
|
259,920
|
|
Zheqing (Simon) Shen
|
96,500
|
135,920
|
—
|
232,420
|
|
Edwina D. Woodbury
|
129,000
|
135,920
|
—
|
264,920
|
|
Steven J. Lund
|
—
|
—
|
1,160,484(3)
|
1,160,484
|
| (1) |
On June 3, 2020, each of the directors listed above except for Mr. Lund, who is an employee, was granted 3,612 restricted stock units, which will vest on April 30, 2021. The amounts reported in this column reflect
the aggregate grant date fair value of the restricted stock units. For this purpose, the value of the restricted stock units is discounted to reflect that no dividends are paid prior to vesting.
|
The outstanding stock and option awards held at December 31, 2020 by each of the listed individuals are as follows:
|
Name
|
Stock Awards
|
Option Awards
|
|
Daniel W. Campbell
|
3,612
|
15,000
|
|
Andrew D. Lipman
|
3,612
|
15,000
|
|
Laura Nathanson
|
3,612
|
—
|
|
Thomas R. Pisano
|
3,612
|
10,000
|
|
Zheqing (Simon) Shen
|
3,612
|
5,000
|
|
Edwina D. Woodbury
|
3,612
|
5,000
|
|
Steven J. Lund
|
—
|
—
|
| (2) |
This column reports our incremental cost for providing perquisites and other personal benefits to those directors whose total was at least $10,000, as well as other forms of compensation.
|
| (3) |
Consists of Mr. Lund’s compensation as an employee of the company for 2020: $570,022 in salary; a cash incentive plan bonus of $549,252; discretionary bonuses of $4,350 (consisting of the same payments made to
corporate employees as described in footnote 2 of the Summary Compensation Table and a $3,500 bonus for reaching a years-of-service milestone); and $36,860 in other compensation, including $20,623 in premiums for life insurance, $11,400 in
401(k) contributions, company products, home security monitoring and premiums for long-term disability insurance.
|
COMPENSATION DISCUSSION AND ANALYSIS
Our Compensation Discussion and Analysis (“CD&A”) describes our executive compensation programs and compensation decisions in 2020 for our named executive officers (“NEOs”), who for 2020 were:
|
Ritch N. Wood
|
Chief Executive Officer
|
|
Ryan S. Napierski
|
President
|
|
Mark H. Lawrence
|
Executive Vice President and Chief Financial Officer
|
|
Joseph Y. Chang
|
Executive Vice President of Product Development and
Chief Scientific Officer
|
|
D. Matthew Dorny
|
Executive Vice President and General Counsel
|
2020 Business Performance Highlights
Amidst a challenging year, our revenue increased 7% in 2020 to $2.58 billion, while earnings per share improved 17% to $3.63. Both our customer and sales leader numbers improved during the year,
increasing 34% and 29%, respectively. These improvements came as a result of focusing on our growth strategy and capitalizing on opportunities available to us through our prior investments in product innovation, technology and manufacturing to build
our customer base and empower our sales leaders. We experienced strong growth in our Americas/Pacific, EMEA and Manufacturing segments. Additionally, we strengthened our balance sheet, repurchased more than five million shares of stock and increased
our dividend for the 19th consecutive year.
We continue to believe we have the correct strategy in place to drive sustained growth in our business. Our growth strategy remains focused on three key elements:
| − |
Innovative Products. We are building on our history of offering innovative and effective products to our customers, highlighted by the recent success of
our new ageLOC Boost™ device and Nutricentials Bioadaptive Skin Care™. We have a robust, multi-year roadmap for both beauty and wellness products and a new product personalization strategy, which we refer to as EmpowerMe.
|
| − |
Empowering Programs. With COVID-19 dramatically changing the way we live, work and interact, our talented sales force adopted our social commerce
strategy by more efficiently and effectively connecting with consumers seeking innovative beauty and wellness products. Through our opportunity platform, our sales force can access hundreds of Nu Skin® personal care and Pharmanex® wellness
products to meet their customers' personal needs, and we look forward to expanding this model across the world.
|
| − |
Digital Platform. We are focused on combining our new social commerce business model with the best of our traditional person-to-person model and
expanding it into a socially enabled, digital-first affiliate business. Currently, more than 90% of our revenue flows from online transactions. We are rapidly leveraging technology to scale our business to grow our customers, and our
efforts are paying off, as we reached more than 1.5 million active customers in 2020.
|
Our business strategy and the successes we achieved in 2020 reflect management’s strong motivation to achieve revenue growth and expand our customer base.
COVID-19 Response
At Nu Skin, our mission is to empower people to improve lives everywhere. This commitment was more important than ever in 2020 as so many of our customers, employees and members of our sales force
managed through the COVID-19 pandemic. To this end, we took the following actions to protect and empower our community:
| − |
Customers. As always, all products are produced using our 6S Quality Assurance Process, which entails high standards for both safety and quality. In
addition, we are conducting increased cleaning and sanitization procedures in our manufacturing and shipping facilities, while also screening employees before they enter our facilities.
|
| − |
Sales Force. With operations in approximately 50 markets, we have contributed to COVID-19 response efforts around the world and have provided regular
guidance to our sales force with respect to applicable government-issued guidelines and recommendations. Many members of our sales force have kept in regular contact with their customers and teams through virtual tools, and we continue to
support their ability to operate virtually with online ordering and direct shipping of products to end consumers.
|
| − |
Employees. We are fully committed to providing a safe and healthy work environment for our employees. Employees in the hardest-hit markets have been and
still are working remotely where possible. For those employees who work in functions such as manufacturing and shipping who cannot work from home, we have strengthened guidelines and communications regarding hygiene practices and have added
access to hand sanitizer stations throughout our facilities. In addition, we have implemented social-distancing practices within the workplace and increased cleaning and sanitization throughout our facilities. Finally, all non-essential
employee travel has been suspended, and we are using digital resources to hold meetings and run the business.
|
2021 CEO Transition
On February 8, 2021, Mr. Wood informed the Board of Directors that he will retire as CEO, effective September 1, 2021. Mr. Wood has agreed to remain with our company through early 2022 to support the
leadership transition by providing advice, guidance and assistance following the conclusion of his service as CEO.
On February 9, 2021, the Board appointed Mr. Napierski as the CEO, effective upon Mr. Wood’s departure as CEO in September 2021. It is anticipated that Mr. Napierski will begin taking on additional
responsibilities over the next several months in preparation for the leadership transition in September.
On February 10, 2021, the Executive Compensation Committee (the "Committee") determined that Mr. Wood will continue with his current salary of $1,000,000 and target bonus percentage of 110% of salary
until he steps down as CEO, at which time his annual salary will decrease to $550,000 and his target bonus percentage will be 60% for the remainder of his time with Nu Skin. The Committee also approved the grant of restricted stock units to Mr. Wood
having a grant value of approximately $1,167,000 (approximately one-third of the value of his typical award), reflecting his one remaining year of service to our company. These restricted stock units will vest in full on February 15, 2022.
Mr. Napierski’s compensation as CEO will be determined at a later date. There are no arrangements or understandings between Mr. Napierski and any other person pursuant to which he was selected as CEO.
Our Commitment to Pay for Performance
The primary objectives of our executive compensation program are:
| 1. |
To successfully recruit, motivate and retain experienced and talented executives; and
|
| 2. |
To ensure pay for performance through incentives that
|
a. Are tied to corporate and individual performance,
b. Align the financial interests of our executives with those of our stockholders and
c. Drive superior stockholder value.
The program, which is administered by the Committee, is intended to align actual compensation payments to actual performance and to adjust upward during periods of strong performance and downward when
performance is short of expectations.
Our NEOs’ 2020 target compensation was divided into variable compensation (cash incentive bonus and equity awards) and fixed compensation (salary) as follows:
The following table describes the metrics upon which NEOs earn each component of variable compensation.
|
Cash Incentive Bonuses
20% of CEO 2020 Target Pay
24% of Other NEOs' 2020 Target Pay
|
Long-Term Incentives
62% of CEO 2020 Target Pay
47% of Other NEOs' 2020 Target Pay
|
||
|
Annual Incentive
|
Time-Based Restricted Stock Units (RSUs)
40% weighting
|
Performance-Based Stock Options
60% weighting
|
|
|
Measures one-year financial performance (2020)
|
Measures four-year stock price performance (2020-2023)
|
Measures one-year financial performance over three years (2020, 2021, 2022)
|
|
|
Metric: Adjusted
revenue
|
Metric: Adjusted operating income
|
Metric: Stock price
|
Metric: Adjusted EPS
|
|
50% weighting
|
50% weighting
|
||
|
Incentivizes business growth
|
Incentivizes profitability and control of expenses
|
Aligns management with
stockholders’ interests
Promotes multi-year retention
|
Aligns management with
stockholders’ interests
Provides a balance to the top-line and operating-income metrics in the cash incentive bonus program
|
|
Both metrics are calculated on a constant-currency basis from the prior-year period and are adjusted to eliminate extraneous items such as the impact of accounting changes, losses or gains on settlements of
litigation that began prior to 2020 and other unusual impacts at the Committee’s discretion.
|
Final value of award tied to stock price.
|
Adjusted EPS is calculated to eliminate extraneous items such as the impact of accounting changes, losses or gains on settlements of litigation that began prior to 2020 and other items that are unusual,
non-recurring or outside of management’s control.
|
|
Our financial results for 2020 met or exceeded the performance goals established at the beginning of the year, and our 2020 cash incentive bonuses and the first tranche of our 2020 performance-based
stock option awards ("PSO awards") were earned above target. That said, the financial results for 2020 fell below threshold for the 2018 and 2019 performance-based stock option awards as such goals, at the time they were set, did not fully anticipate
the impact of certain headwinds that we would face, including government and media scrutiny of the health products and direct selling industries in Mainland China in 2019, our lack of a major product launch in 2019 and the COVID-19 pandemic in 2020.
Consistent with our commitment to pay for performance, these 2018 and 2019 awards were not earned, nor were any adjustments made to them in response to the COVID-19 pandemic.
|
Performance-Based Award
|
Percent of Target Earned
|
|
2020 Cash Incentive Bonus(1)
|
161%
|
|
2018 PSO Awards – Tranche 3 of 3 (measuring 2020 results)(2)
|
0%
|
|
2019 PSO Awards – Tranche 2 of 3 (measuring 2020 results)(2)
|
0%
|
|
2020 PSO Awards – Tranche 1 of 3 (measuring 2020 results)(2)
|
200%
|
| (1) |
Contingent on 2020 adjusted revenue and adjusted operating income.
|
| (2) |
Represents the tranches of the respective three-year awards that were contingent on 2020 adjusted EPS, as determined at the time of grant.
|
2020 Say-on-Pay Vote
At our 2020 annual meeting of stockholders, 98% of the votes cast were in favor of our executive compensation program. When designing our 2021 executive compensation program, the Committee considered,
among other things, the 2020 voting results and other feedback we received from our stockholders, which were viewed as supportive of our pay philosophy and incentive framework.
Continuing Adherence to Compensation Governance Best Practices
We have a framework of strong corporate governance related to compensation, illustrated as follows:
|
What We Do
|
What We Don’t Do
|
|
|
✔
|
Link pay outcomes directly to company and share price performance in support of a pay for performance philosophy |
û No evergreen employment agreements
û No hedging or pledging of Nu Skin shares
û No excessive perquisites
û No excise tax gross-ups for NEOs
û No payment of current dividends on unvested equity
û No repricing of stock options without stockholder approval
|
| ✔ | Utilize multiple, complementary incentive measures in the annual and long-term incentive plans that align with key drivers of stockholder value creation | |
|
✔ Utilize double-trigger change in control benefits
✔ Employ a comprehensive clawback policy
✔ Require robust equity retention for directors and executives
✔ Assess compensation risk annually
✔ Engage an independent compensation consultant
|
||
Stockholder Outreach
Continuing our annual stockholder outreach program, during 2020 we reached out to investors representing approximately 42% of our outstanding shares, generally covering holders of at least 1% of our
outstanding shares. We value the input of our stockholders, and the outreach process is an opportunity to:
| − |
Solicit our stockholders’ feedback and better understand their perspectives on executive compensation so that the Committee can take those philosophies into account as it evaluates possible program changes;
|
| − |
Answer any questions that stockholders may have with respect to our existing programs and practices or past decisions; and
|
| − |
Establish a platform for ongoing dialogue with our stockholders.
|
Objectives
The primary objectives of our compensation program are to:
| − |
Successfully recruit, motivate and retain experienced and talented executives;
|
| − |
Provide competitive compensation arrangements that are tied to corporate and individual performance in the short- and long-term;
|
| − |
Align the financial interests of our executives with those of our stockholders; and
|
| − |
Drive superior stockholder value over the long-term.
|
The Committee, in consultation with management and the Committee’s independent advisors, oversees the executive compensation and benefits program for the company’s NEOs. The compensation program is
comprised of a combination of base salary, an annual cash incentive and equity incentives, each intended to support the above-noted objectives.
|
Component of Compensation Program
|
Objective
|
|
Base Salary
(Fixed Pay)
|
− Pay for role
− Aids in recruitment and retention
|
|
Cash Incentive Plan
(Short-Term Incentive)
|
− Pay for performance
− Aligns with annual operating achievement
− Aids in recruitment and retention
|
|
Equity Incentive Plan
(Long-Term Incentive)
|
− Pay for performance
− Aligns with stock price performance and multi-year operating achievement
− Aids in recruitment and retention
|
We also provide retirement benefits in the form of a 401(k) plan and a deferred compensation plan, as well as limited perquisites and other personal benefits to executives that represent a small portion
of their overall compensation.
For 2020, our NEOs’ target compensation consisted of the following components:
Base Salary
Base salaries are provided to reflect each NEO’s responsibilities, function, performance and competencies. In establishing and approving base salaries, the Committee considers various factors including:
| − |
Current market practices and salary levels;
|
| − |
Each executive officer’s responsibilities, experience in their position and capabilities;
|
| − |
Individual performance and company performance;
|
| − |
The relative role and contribution of each NEO in the company;
|
| − |
Competitive offers made to executive officers and the level of salary that may be required to recruit or retain executive officers; and
|
| − |
The recommendations of the CEO.
|
Base salaries for executive officers are typically reviewed annually, in the first quarter of each year. The Committee does not assign specific weights to the factors identified above but generally
endeavors to establish base salaries that are competitive in relation to the peer group median in order to attract and retain qualified and effective executive officers.
In the first quarter of 2020, the Committee reviewed the base salaries of each of the NEOs in connection with the established annual review process and determined to increase the salaries by a range of
0% to 5%. The NEOs’ salaries, together with the prior salaries that were reviewed in the first quarter of 2020, are as follows:
|
Name
|
Prior Salary
($)
|
Adjusted Salary
($)
|
Increase
($)
|
Increase
(%)
|
||||
|
Ritch N. Wood
|
1,000,000
|
1,000,000
|
—
|
—
|
||||
|
Mark H. Lawrence
|
500,000
|
525,000
|
25,000
|
5%
|
||||
|
Ryan S. Napierski
|
700,000
|
725,000
|
25,000
|
4%
|
||||
|
Joseph Y. Chang
|
660,000
|
675,000
|
15,000
|
2%
|
||||
|
D. Matthew Dorny
|
510,000
|
510,000
|
—
|
—
|
Cash Incentive Bonus
Metrics. Cash incentive bonuses are measured based on achievement of goals related to adjusted revenue and adjusted operating
income. These two metrics are equally weighted because management is responsible for both growing the business and increasing profitability, including control of expenses.
|
Metric
|
Weighting
|
Purpose
|
How Calculated
|
|
Adjusted revenue
|
50%
|
Incentivizes business growth
|
Both metrics are calculated on a constant-currency basis from the prior-year period and are adjusted to eliminate extraneous items such as the impact of accounting changes, losses or gains on settlements of
litigation that began prior to 2020 and other unusual impacts at the Committee’s discretion.
|
|
Adjusted operating income
|
50%
|
Incentivizes profitability and control of expenses
|
Target Bonus. Cash incentive bonuses are computed based on the degree to which pre-determined goal performance levels are met or
exceeded. If goal performance levels are met for a particular incentive period, a participant will earn a bonus equal to a pre-established percentage of salary, the “target bonus.” We set the target bonus as a percentage of base salary based on an
executive officer’s position and responsibility and on market practices. The following table provides the target bonus percentage (as a percentage of salary) for each of our NEOs in 2020.
|
Named
Executive Officer
|
2020 Target Bonus %
|
|
|
Ritch N. Wood
|
110%
|
|
|
Mark H. Lawrence
|
75%
|
|
|
Ryan S. Napierski
|
100%
|
|
|
Joseph Y. Chang
|
75%
|
|
|
D. Matthew Dorny
|
75%
|
Calculation of Bonus: Achievement of Performance Goals and Adjustment for Individual Performance. The precise percentage of target
bonus that a participant will earn is based on the degree to which pre-determined performance levels are met or exceeded.
The 2020 cash incentive bonus program included a payout opportunity of 25% of target based on minimum level achievement of annual performance goals. Previously, this payout opportunity was 50%. No
changes were made to the relationship between performance achievement and payout opportunity at the target and stretch levels.
Note that:
| − |
If actual results for a particular incentive period equal:
|
| o |
Goal performance levels – The bonus amount will be the participant’s target bonus amount for the incentive period.
|
| o |
Minimum performance levels – The bonus amount will be 25% of the participant’s target bonus amount for the incentive period.
|
| o |
Stretch performance levels – The bonus amount will be 200% of the participant’s target bonus amount for the incentive period.
|
| − |
Payouts are interpolated linearly if actual results fall between the minimum and goal measurement points or between the goal and stretch measurement points.
|
| − |
If the minimum adjusted operating income performance level is not met, no bonus is paid regardless of the adjusted revenue performance for that period.
|
| − |
If the minimum adjusted operating income performance level is met but the minimum adjusted revenue performance level is not, 12.5% of the target bonus for the incentive period is earned.
|
Notwithstanding the above methodology, the Committee may adjust an executive’s bonus based on factors it considers relevant, including individual performance and certain
compliance-related objectives. The Committee did not exercise this discretion with respect to 2020 bonuses.
Establishment of 2020 Performance Goals. In establishing the performance levels, the Committee considered various factors,
including industry, market and peer estimated growth rates; our recent performance and current business plans; general business and economic conditions; business risks; uncertainties due to COVID-19 and our company’s strategic objectives, which for
2020 included enhancing customer experiences across all our digital touch points, launch of our new ageLOC Boost beauty device system, and expanding our customer loyalty programs around the world to enhance retention and lifetime value.
After considering the above factors, the Committee set the 2020 performance goals, as outlined in the table below.
2020 Goals, Performance and Payout. The table below sets forth the 2020 performance goals, the actual performance, the percentage
of the goal performance levels achieved and the percentage of the target bonus that was paid.
|
(dollar amounts in thousands)
|
||||||||
|
Metric
|
2019
Result
|
2020 Targets
|
2020 Result
|
% of Goal Level Achieved
|
% of Target Bonus Paid
|
|||
|
Minimum
|
Goal
|
Stretch
|
||||||
|
Adjusted revenue
(50% weighting)
|
$2,420,416
|
$2,175,000
|
$2,420,000
|
$2,662,000
|
$2,594,120
|
107.2%
|
172.0%
|
|
|
Adjusted operating income (50% weighting)
|
$267,426
|
$177,000
|
$217,000
|
$293,000
|
$254,436
|
117.3%
|
149.3%
|
|
|
Aggregate payout percentage, reflecting the weightings noted above:
|
160.6%
|
|||||||
Our 2020 results, created in a year of extreme uncertainty, benefited from our strategic shift to become a more digital business, particularly in our Americas/Pacific and EMEA segments, as well as the
current environment where consumers are spending more time online and working from home, together with the launch of ageLOC Boost. As a result, our adjusted revenue grew 7.2% over 2019 results. Adjusted operating income declined 4.9%. These results
met and exceeded the performance goals established at the beginning of the year, and consistent with our commitment to pay for performance, the cash incentive awards were earned in 2020.
The percentage of target bonus paid does not rise or fall 1% for every 1% increase or decrease in the percentage of goal performance level achieved. For example, in 2020, we achieved 107.2% of our goal
adjusted revenue level and paid 172.0% of the portion of target bonus that was based on adjusted revenue. Similarly, if our actual performance had been 99% of our goal adjusted revenue level, we would have paid less than 99% of the portion of target
bonus that was based on adjusted revenue.
Calibration of Equity Awards
Aligning the interests of our executive officers with those of our stockholders is an important objective of our compensation program. To accomplish this objective, we tie a significant portion of our
executive officers’ total compensation to our long-term stock performance through the grant of equity awards and to our equity retention guidelines, which require our executive officers to retain a specified amount of their equity. We also believe
that equity compensation helps motivate executive officers to drive earnings growth because they will be rewarded with increased equity value, and assists in the retention of executive officers who may have significant value tied up in unvested
equity awards.
We periodically review and adjust the level of our equity awards. We do not use a fixed formula or criteria in determining whether to adjust the level of equity awards, but subjectively evaluate a
variety of factors, such as:
|
− Practices of peer companies
− Degree of responsibility for overall corporate performance
− Overall compensation levels
− Changes in position and/or responsibilities
− Individual performance
− Company performance
− Total stockholder return
|
− Degree of performance risk in the equity grant program
− Potential dilution of our overall equity grants
− Accumulated realized and unrealized value of past equity awards
− Associated expenses of equity awards
− The recommendations of the CEO
− Data and context provided by our compensation consultant
|
Historically, we have referenced peer company compensation data for context on pay levels and performance requirements compared to our peers. We generally have not given significant consideration to the
value of existing equity award holdings because we want to ensure that our equity compensation is competitive for the position on an annualized basis and we want to provide an incentive from the date of grant. However, we periodically review and
consider the in-the-money value of existing award holdings of our executive officers in connection with our review of equity compensation practices to determine if wealth creation is aligning with performance and the amount of unvested equity in
place for retention.
As reflected in the following table, the equity awards granted to the NEOs in 2020 were heavily weighted with performance-based awards, generally tracking the 60% weighting that the Committee adopted
based on stockholder feedback.
|
2020 TARGET EQUITY AWARDS (1)
|
||||
|
Percentage Perf.-Based
|
||||
|
Named
Executive Officer
|
Perf.-Based
Stock
Options (2)
|
Time-Based
RSUs
|
Number
of
Awards
|
Grant Date
Fair Value
|
|
Ritch N. Wood
|
244,471
|
45,978
|
84%
|
56%
|
|
Mark H. Lawrence
|
69,849
|
13,137
|
84%
|
56%
|
|
Ryan S. Napierski
|
105,821
|
19,902
|
84%
|
56%
|
|
Joseph Y. Chang
|
49,593
|
9,327
|
84%
|
56%
|
|
D. Matthew Dorny
|
49,593
|
9,327
|
84%
|
56%
|
| (1) |
During 2020, the Board of Directors sought shareholder approval for an amendment to our 2010 Omnibus Incentive Plan to increase the authorized shares under the Plan, among other things. With limited shares
available, performance-based stock options were granted as part of our annual grant cycle in February, and time-based restricted stock units were granted after approval of the amended Plan in June.
|
| (2) |
Reflects the number of shares of stock that become eligible for vesting or exercisable if performance is achieved at the goal performance level, the same number used for calculating grant date fair value for
purposes of the Summary Compensation Table.
|
Use of Performance-Based Equity Awards
Although we consider time-based stock options to be performance-based because the stock price must increase after the grant for value to be realized, we believe that the performance nature of our equity
grants is further enhanced by making a meaningful portion of equity grants in the form of performance-contingent stock options that are earned for achieving multi-year performance goals. To align management with our stockholders’ interests, the
performance goals are tied to adjusted EPS, measured as diluted EPS excluding extraneous items such as the impact of accounting changes, losses or gains on settlements of litigation that began prior to 2020 and other items that are unusual,
non-recurring or outside of management’s control. The adjusted EPS metric also provides a balance to the top-line and operating-income metrics in the cash incentive bonus program.
Consistent with our historical practice, NEOs earn 100% of their target award if performance is at goal level, and they earn 50% of their target award if performance is at the minimum level. The terms
of the performance-based equity awards that were granted in 2019 and 2020 give NEOs the opportunity to earn up to 200% of their target award if performance meets certain pre-defined “super stretch” levels. This closely aligns the maximum payout
opportunity with competitive practice and further strengthens our alignment with stockholders. The terms of the performance-based equity awards granted to the NEOs in 2018 limited the opportunity to earn up to 150% of their target award.
Our performance-based equity awards are divided into three equal tranches. The three tranches are contingent on performance over the year of the grant and the two following years, respectively. Although
the grants measure three one-year periods, the goals for all three years are established up front at the time of grant to ensure a longer-term orientation without the “reset” of goals each year.
Performance-Based Equity Awards – Goals and Vesting
Our performance-based equity awards granted in the past several years have generally required continuous improvement in adjusted EPS results. They have been structured with three tranches, with vesting
contingent on the achievement of adjusted EPS goals in the year of grant and in each of the two following years. The goals for all three of these one-year periods are set at the time of grant.
Awards Under 2018–2020 Compensation Programs. As illustrated in the table below, for performance-based equity awards granted in
2018 and 2019, the minimum goals for the year of grant required growth over the previous year’s actual adjusted EPS, and the minimum goals for the two subsequent years required adjusted EPS to be at or above the respective prior years’ target
adjusted EPS.
In light of the anticipated negative impacts from the COVID-19 pandemic, the Committee established adjusted EPS goals for the first year of the 2020 performance-contingent equity awards at a level that
was below the previous year’s actual adjusted EPS. While the goals for the two subsequent years required adjusted EPS growth for an equivalent payout, the ranges around target (to minimum and to maximum) were increased to reflect the increased
uncertainty in the operating environment, particularly due to COVID-19, and no longer required growth above the prior year’s target at the minimum level.
|
Minimum
Goal ($)
|
Target
Goal ($)
|
Maximum
Goal ($)
|
Actual ($)
|
% Vested
|
|
|
2018 Award
|
|||||
|
➢ 2017 Adjusted EPS: 3.23(1)
|
|||||
|
2018 Adjusted EPS Tranche
|
3.33
|
3.52
|
3.73
|
3.61(2)
|
121%
|
|
2019 Adjusted EPS Tranche
|
3.52
|
3.70
|
3.92
|
3.10(3)
|
—
|
|
2020 Adjusted EPS Tranche
|
3.70
|
3.88
|
4.11
|
3.63(3)
|
—
|
|
2019 Award
|
|||||
|
➢ 2018 Adjusted EPS: 3.61(2)
|
|||||
|
2019 Adjusted EPS Tranche
|
3.68
|
3.98
|
4.38
|
3.10(3)
|
—
|
|
2020 Adjusted EPS Tranche
|
3.98
|
4.20
|
4.62
|
3.63(3)
|
—
|
|
2021 Adjusted EPS Tranche
|
4.20
|
4.45
|
4.97
|
TBD
|
TBD
|
|
2020 Award
|
|||||
|
➢ 2019 Adjusted EPS: 3.10(3)
|
|||||
|
2020 Adjusted EPS Tranche
|
2.00
|
2.50
|
3.60
|
3.63(3)
|
200%
|
|
2021 Adjusted EPS Tranche
|
2.10
|
2.62
|
3.78
|
TBD
|
TBD
|
|
2022 Adjusted EPS Tranche
|
2.21
|
2.75
|
3.97
|
TBD
|
TBD
|
| (1) |
As compared to our 2017 reported EPS of $2.36, our adjusted EPS reflects an adjustment of $0.87 to reflect the net impact of the 2017 tax reform legislation in the United States.
|
| (2) |
As compared to our 2018 reported EPS of $2.16, our adjusted EPS reflects adjustments totaling $1.45 from a charge associated with the conversion of our convertible notes in the first quarter of 2018, adoption of the
new revenue standard under U.S. GAAP, the impairment and restructuring charges incurred in the fourth quarter of 2018, and both a gain and a charge associated with the acquisitions in the first quarter of 2018. These adjustments were
permitted by the terms of the awards granted in 2018.
|
| (3) |
No adjustments were made to our 2019 reported EPS of $3.10 or our 2020 reported EPS of $3.63.
|
Time-Based Equity Awards
Each NEO received an annual time-based RSU grant in 2020. These RSUs will vest one-fourth each year, beginning on February 15 of the year following the grant. The 2020 time-based RSU awards
align management with stockholders’ interests and promote multi-year retention.
Retirement and Other Post-Termination Benefits
Our executive officers do not participate in any pension or defined benefit plan. We believe it is important for retention purposes to provide executive officers with a meaningful opportunity to
accumulate savings for their retirement. To accomplish this objective, we maintain both a tax-qualified 401(k) plan and a nonqualified deferred compensation plan. We make a limited matching contribution for our employees, including NEOs, under the
401(k) plan. We also make contributions to each NEO’s deferred compensation plan account. Effective in 2021, our deferred compensation plan was modified to provide a matching contribution by the company for individual contributions up to a maximum of
5% of base salary. In addition, we generally make a discretionary contribution, expected to be reduced from the historical amount of 10% of salary to approximately 5% of salary.
As more fully described and quantified below in “Executive Compensation Tables and Accompanying Narrative—Narrative to Summary Compensation Table and Grants of Plan Based Awards Table—Employment
Agreement with Mr. Chang” and in the table titled “Potential Payments Upon Termination or Change in Control,” we have an executive employment agreement with Mr. Chang that provides for certain termination benefits. The Committee has also adopted an
Executive Severance Policy that applies to all of our NEOs.
We do not provide excise tax gross-up protection to any of our NEOs. Any cash severance payment under these arrangements or accelerated vesting of equity in connection with a change in control requires
a qualifying termination of employment. We believe these double-trigger post-termination benefits provide reasonable protections to employees who may be terminated following a change in control. They also assist us in retaining their services in the
event of a potential change in control. We believe such arrangements are in the best interests of our company and our stockholders if they are reasonable in amount and scope, because they can help to retain key employees during a change in control
process.
Perquisites and Other Benefits
We provide our executive officers and other key employees with other limited benefits and perquisites. These consist of, among other things, payments for term life insurance, use of company-owned
properties, sporting event tickets, company products and sales force event-related spouse travel. We do not reimburse executive officers for the income taxes associated with these perquisites except for limited business-related perquisites such as
spouse travel to sales force events where the spouse is expected to attend and help entertain and participate in events with our sales force and their spouses. We have elected to pay the income taxes for these business-related perquisites because we
believe they are business expenses. These benefits generally represent a very small portion of an executive officer’s overall compensation and provide a benefit to us and our stockholders. Mr. Napierski additionally received tax payments associated
with income received as a result of his former expatriate assignment. The amount of these benefits is included in footnote 5 to the Summary Compensation Table.
Role of Executive Compensation Committee and Chief Executive Officer
The Committee is responsible for establishing and administering our executive compensation program. The Committee participates in the performance evaluation process of the Chairman and of the CEO, which
process is led by the Nominating and Corporate Governance Committee. The Committee is then responsible for setting their compensation. The CEO, with oversight by the Nominating and Corporate Governance Committee, is responsible for evaluating the
performance of the other executive officers and then making recommendations to the Committee with regard to the compensation packages for these officers. The Committee reviews any such recommendations and has the authority to approve, revise or
reject such recommendations.
Role of Compensation Consultant
The Committee has retained the services of Semler Brossy Consulting Group LLC (“Semler Brossy”) as its independent compensation consultant to assist in the review of our executive compensation program,
to provide compensation data and alternatives to the Committee, and to provide advice to the Committee as requested, including limited advice regarding employee equity grants and the compensation programs of our subsidiary companies when requested by
the Committee. The Committee utilizes the compensation data and alternatives provided by the compensation consultant to analyze compensation decisions in light of current market rates and practices. During 2020, Semler Brossy did not perform any work
for us outside of the services performed for the Committee and for the Nominating and Corporate Governance Committee with respect to director compensation.
The Committee annually reviews the independence of its compensation consultant in light of SEC rules and NYSE Listed Company Rules regarding compensation consultant independence and has concluded that
Semler Brossy is independent from the company and has no conflicts of interest related to its engagement by the Committee.
Use of Competitive Data
The Committee uses peer group information in making compensation decisions. The Committee compares compensation proposals to the compensation practices of a peer group of publicly-traded companies that
compete with us broadly in the consumer products industry—with a preference for those with a direct selling business model—and are similar in size to us.
The Committee reviews and updates the peer group from time to time to ensure it is utilizing an appropriate group in terms of size and relevance. Following such a review, in 2018 the Committee
determined to update the peer group such that it would include fewer companies larger than 200% of our revenue and market capitalization, position Nu Skin closer to the peer median for revenue, and make the group represent our company’s most direct
competitors from a business-model and product-focus perspective. At the time that the peers were approved in 2018, Nu Skin’s revenue was 7% below the peer median for revenue.
Following a review of the peer group, in November 2019, the Committee determined to update the peer group to ensure it continued to reflect companies in our industry and approximate revenue size. As a
result, the Committee removed GNC Holdings, Inc. from the peer group and added Spectrum Brands Holdings, Inc. Following this change in peers, Nu Skin’s revenue was 13% above the peer median for revenue. The newly constituted peer group was used in
making compensation decisions for 2020, and it consists of the following companies:
|
− Avon Products, Inc.(1)
|
− Primerica, Inc.
|
|
− Church & Dwight Co., Inc.
|
− Revlon, Inc.
|
|
− Edgewell Personal Care Company
|
− Sally Beauty Holdings, Inc.
|
|
− The Hain Celestial Group, Inc.
|
− Sensient Technologies Corporation
|
|
− Helen of Troy Limited
|
− Spectrum Brands Holdings, Inc.
|
|
− Herbalife Nutrition Ltd.
|
− Tupperware Brands Corporation
|
|
− International Flavors & Fragrances Inc.
|
− USANA Health Sciences, Inc.
|
|
− Prestige Consumer Healthcare Inc.
|
| (1) |
Acquired by Natura &Co Holding S.A., a Brazilian corporation, in January 2020.
|
In August 2020, the Committee removed Avon Products, Inc. from the peer group due to its acquisition by Natura &Co Holding S.A. Following this change in peers, Nu Skin’s revenue was 6% above the
peer median for revenue. The newly constituted peer group was used in making compensation decisions for 2021.
Mix of Compensation
When the Committee reviews an executive officer’s compensation, it does not use a specific formula or allocation target to establish the level or mix of total compensation. Rather, it exercises judgment
in determining a compensation package that is appropriate to accomplish our compensation objectives under the circumstances applicable to the executive officer. The Committee also reviews the relative mix of compensation provided by other companies
in our peer group for context and tries to ensure each component is competitive. Historically, we have tied a substantial amount of compensation to corporate performance under our cash incentive plan and equity incentive plan.
The Committee also reviews each executive officer’s total compensation as a market check against the total compensation of executive officers in our peer group. This total compensation review focuses on
base salary, cash bonuses, and valuation of equity grants using grant date valuations. The Committee periodically reviews perquisites and retirement benefits to confirm that they remain relatively consistent with the value of perquisites and
retirement benefits provided by our peer companies.
Risks Arising From Compensation Policies and Practices
In establishing and reviewing the components of compensation, the Committee considers potential risks associated with such components. In addition, our management conducted a review of our compensation
policies and practices for employees and concluded that risks arising from our compensation policies and practices for employees are not reasonably likely to have a material adverse effect on us.
In reaching this conclusion, our management considered the following factors:
| − |
Our compensation programs are market driven and balance short-term incentives with significant long-term equity incentives. Performance-contingent equity awards provide additional long-term incentives to our key
employees and executive officers. In addition, our equity retention guidelines help to ensure that a portion of our executives’ equity incentives remains tied to our long-term performance.
|
| − |
Our global cash incentive compensation is based on revenue and profitability, which are core measures of performance. In addition, substantially all of our revenue is received through cash or credit card payments,
as opposed to other credit arrangements, which minimizes risk associated with our revenue-based incentives. Additionally, the Board of Directors and management regularly review the business plans and strategic initiatives, including related
risks, proposed to achieve such performance metrics.
|
| − |
A substantial portion of compensation is provided in the form of long-term equity incentives with multi-year vesting.
|
| − |
We do not allow engagement in speculative trading or hedging. Our policies prohibit all of our directors and employees, including executive officers, from holding our stock in margin accounts and from engaging in
speculative transactions in our stock, including short sales, options or hedging transactions. Our directors and employees, including executive officers, also are prohibited from pledging their securities in our company.
|
Clawback Policy
Pursuant to our Third Amended and Restated 2010 Omnibus Incentive Plan (the "Plan"), any and all awards granted under the Plan will be canceled if the participant violates a non-competition,
non-solicitation or non-disclosure covenant or agreement or otherwise engages in activity or material misconduct that is in conflict with or adverse to our interests, including conduct contributing to any financial restatements or financial
irregularities, as determined by the Committee. In addition, all compensation awarded under our current and prior plans will be subject to recovery or other penalties pursuant to (i) any future clawback policy of the company, as may be adopted or
amended from time to time; (ii) any clawback provision set forth in an award agreement; and (iii) any applicable law, rule or regulation or applicable stock exchange rule, including, without limitation, Section 304 of the Sarbanes-Oxley Act of 2002,
Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, Section 10D of the Securities Exchange Act of 1934 and any applicable stock exchange listing rule adopted pursuant thereto. Further, if we are required to prepare an
accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws, the Committee may terminate any awards granted under our current and prior plans and/or require any participant to reimburse us
for the amount of any payment or benefit received with respect to such awards to the extent they would not have been earned or accrued after giving effect to the restatement.
Consistent with the Plan, our equity incentive awards and our cash incentive awards contain cancellation, clawback and recoupment provisions that allow the Committee to recover an executive’s gains from
such awards if the executive materially breaches certain obligations or covenants, including non-competition, non-solicitation and non-disclosure covenants, or willfully engages in or is convicted of certain illegal activity, fraud or other
misconduct. In such event, we may terminate the outstanding awards of such executive and recover any gains from the awards during the twelve months preceding the act or anytime thereafter. Our cash incentive awards and performance-based equity awards
additionally include similar cancellation, clawback and recoupment provisions that apply in the case of a financial restatement to the extent the award would not have been earned or accrued after giving effect to the restatement.
Equity Retention Guidelines
Our equity retention guidelines are designed to motivate our executive officers and directors to consider the long-term consequences of business strategies and to provide a level of long-term
performance risk with respect to our compensation programs. These guidelines generally require executive officers and directors to retain 50% of the net shares (after payment of the exercise price and related taxes) with respect to any equity award
unless the individual holds a number of shares having a value equal to a multiple of his or her base salary (for executives) or annual cash retainer (for non-management directors), as follows:
|
Position
|
Multiple of Base Salary or
Annual Retainer
|
|
CEO
|
6.0
|
|
Other Executives
|
2.5
|
|
Non-Employee Directors
|
5.0
|
The ownership levels are phased in over five years from January 1 of the year following the date of appointment or election to one’s position as an executive officer or director. In determining whether
an executive officer or director satisfies the designated ownership levels, we count shares owned outright or beneficially by the individual or an immediate family member residing in the same household, as well as a portion of the individual’s
unvested time-based restricted stock units. We do not count vested or unvested options.
As of March 31, 2021, all of our NEOs and directors were retaining equity awards consistent with the guidelines, and all of our NEOs and directors who had served in their positions for the five-year
phase-in period owned the amount of stock designated for their job positions.
Indemnification and Advancement of Expenses
We have entered into indemnification agreements with each of our directors and executive officers, pursuant to which these individuals will be indemnified for certain liabilities and will be advanced
certain expenses that have been incurred as a result of actions to which they were, are, or are threatened to be made a party, or actions otherwise involving them, in connection with their service to the company. The indemnification agreements also
include related provisions outlining the procedures for obtaining such benefits, and they generally require us to obtain and maintain director and officer liability insurance.
Tax Limitations on Deductibility
Section 162(m) of the Internal Revenue Code precludes us from taking a federal income tax deduction for compensation paid in excess of $1 million to our “covered employees” (which include the CEO, CFO
and our three other most highly-compensated NEOs, as well as any other individuals who were covered employees in any prior tax year after 2016). While the Committee has generally taken into consideration the tax deductibility of executive
compensation, the Committee believes that the primary purpose of our compensation program is to support our business strategy and the long-term interests of our stockholders. Therefore, the Committee has maintained the flexibility to award
compensation that may not be tax deductible if doing so furthers the objectives of our executive compensation program.
Under the U.S. tax reform legislation that was enacted in December 2017, the definition of “covered employee” was expanded to include the CFO and covered employees from previous tax years. In addition,
the exception to the Section 162(m) deduction limit for performance-based compensation was repealed for tax years beginning after December 31, 2017, subject to certain transition rules. Despite these new limits on the deductibility of
performance-based compensation, the Committee continues to believe that a significant portion of our NEOs’ compensation should be tied to performance, and it designed our 2018, 2019 and 2020 executive compensation programs accordingly. We currently
expect that any compensation amounts over $1 million paid to any covered employee will no longer be deductible unless they qualify for transition relief applicable to certain arrangements in place as of November 2017.
We have reviewed and discussed with management the Compensation Discussion and Analysis that is included in this proxy statement. Based on such review and discussions, we recommended to the Board of
Directors that the Compensation Discussion and Analysis be included in this proxy statement.
|
EXECUTIVE COMPENSATION COMMITTEE OF
THE BOARD OF DIRECTORS
|
|
|
Thomas R. Pisano, Chairman
|
|
|
Daniel W. Campbell
|
|
|
Andrew D. Lipman
|
|
|
Laura Nathanson
|
Summary Compensation Table
The following table summarizes the total compensation of each of the named executive officers (“NEOs”) for 2018, 2019 and 2020, as calculated in accordance with SEC rules. The amounts in the “Stock
Awards” and “Option Awards” columns do not necessarily reflect the amounts actually earned by the NEOs because they include performance-based equity awards that were granted during the respective year regardless of whether and when they are
ultimately earned, based on company performance.
|
Name and
Principal Position
|
Year
|
Salary
($)(1)
|
Bonus
($)(2)
|
Stock
Awards
($)(3)
|
Option
Awards
($)(3)
|
Non-Equity
Incentive Plan
Compensation
($)(4)
|
All Other
Compensation
($)(5)
|
Total ($)
|
|
Ritch N. Wood
Chief Executive
Officer
|
2020
|
1,000,038
|
850
|
1,642,334
|
2,100,006
|
1,766,600
|
126,730
|
6,636,559
|
|
2019
|
991,667
|
—
|
1,322,140
|
2,111,047
|
—
|
145,526
|
4,570,379
|
|
|
2018
|
941,667
|
40,333
|
611,385
|
2,547,233
|
1,794,993
|
129,999
|
6,065,610
|
|
|
Mark H. Lawrence
Executive VP and
Chief Financial
Officer
|
2020
|
520,853
|
850
|
469,254
|
600,003
|
632,363
|
77,136
|
2,300,459
|
|
2019
|
491,667
|
—
|
1,992,713
|
542,844
|
—
|
98,170
|
3,125,393
|
|
|
2018
|
445,833
|
19,500
|
171,950
|
716,400
|
637,694
|
73,682
|
2,065,059
|
|
|
Ryan S. Napierski
President
|
2020
|
720,861
|
3,350
|
710,899
|
909,002
|
1,164,350
|
104,163
|
3,612,626
|
|
2019
|
687,500
|
—
|
572,325
|
913,788
|
—
|
122,658
|
2,296,272
|
|
|
2018
|
620,833
|
26,792
|
277,046
|
1,154,226
|
1,062,825
|
330,815
|
3,472,537
|
|
|
Joseph Y. Chang
Executive VP of
Product Dev. and
Chief Scientific
Officer
|
2020
|
672,526
|
850
|
333,160
|
426,004
|
813,038
|
102,386
|
2,347,964
|
|
2019
|
653,333
|
—
|
268,229
|
428,239
|
—
|
124,299
|
1,474,100
|
|
|
2018
|
616,667
|
26,583
|
135,634
|
565,166
|
878,602
|
108,417
|
2,331,069
|
|
|
D. Matthew Dorny
Executive VP and
General Counsel
|
2020
|
510,020
|
850
|
333,160
|
426,004
|
614,295
|
69,451
|
1,953,780
|
|
2019
|
504,167
|
—
|
268,229
|
428,239
|
—
|
77,063
|
1,277,698
|
|
|
2018
|
472,833
|
22,542
|
135,634
|
565,166
|
673,123
|
67,260
|
1,936,558
|
| (1) |
Messrs. Lawrence, Napierski, Dorny and, through 2019, Chang deferred a portion of their salaries under our nonqualified Deferred Compensation Plan, which is included in the Nonqualified Deferred Compensation – 2020
table. Each of the NEOs also contributed a portion of his salary to our 401(k) retirement savings plan.
|
| (2) |
The amounts reported in this column for 2020 consist of (i) a gift payment made to all corporate employees as a year-end holiday gift; (ii) cash payments made to all corporate employees in lieu of summer and holiday
company parties that were canceled due to the COVID-19 pandemic; and (iii) in the case of Mr. Napierski, a $2,500 bonus for reaching a years-of-service milestone.
|
| (3) |
The amounts reported in these columns reflect the aggregate grant date fair value of equity awards computed in accordance with FASB ASC Topic 718 and, for performance-based awards, are based on the probable outcome
of the performance conditions as of the grant date. The amounts do not represent amounts actually received by the NEOs. For this purpose, the estimate of forfeitures is disregarded, and the value of the stock awards is discounted to reflect
that no dividends are paid prior to vesting. For information on the valuation assumptions used in calculating these amounts, refer to Note 9 to our financial statements in the Form 10-K filed for the fiscal year ended December 31, 2020.
|
|
The aggregate grant date fair value of the 2020 performance-based option awards, assuming achievement of the maximum performance level, would be: Mr. Wood – $4,200,012; Mr. Lawrence – $1,200,006; Mr. Napierski –
$1,818,005; Mr. Chang – $852,008; and Mr. Dorny – $852,008.
|
| (4) |
See “Executive Compensation: Compensation Discussion and Analysis—Cash Incentive Bonus” for information regarding the amounts reported in this column. For years in which non-equity incentive bonuses were earned,
Messrs. Lawrence, Napierski and Dorny deferred a portion of certain of these bonuses under our nonqualified Deferred Compensation Plan, which deferrals are reflected in the Nonqualified Deferred Compensation – 2020 table.
|
| (5) |
The following table describes the components of the All Other Compensation column for 2020 in the Summary Compensation Table.
|
|
Name
|
Company
Contributions to
Deferred
Compensation
Plan
($)
|
Company
Contributions to
401(k) Retirement
Savings Plan
($)
|
Perquisites and
Other Personal
Benefits
($)(a)
|
Other
($)(b)
|
Total
($)
|
|
Ritch N. Wood
|
100,000
|
11,400
|
13,952
|
1,378
|
126,730
|
|
Mark H. Lawrence
|
52,500
|
11,400
|
10,644
|
2,592
|
77,136
|
|
Ryan S. Napierski
|
72,500
|
11,400
|
9,686
|
10,577
|
104,163
|
|
Joseph Y. Chang
|
67,500
|
11,400
|
11,885
|
11,601
|
102,386
|
|
D. Matthew Dorny
|
51,000
|
11,400
|
5,494
|
1,556
|
69,451
|
| (a) |
This column reports our incremental cost for perquisites and personal benefits provided to the NEOs. In 2020, these included the personal use of company-provided properties; tickets, travel and hospitality for
sporting events; company products; and tax-planning advice.
|
| (b) |
This column includes premiums for long-term disability insurance, and premiums for term life insurance with coverage, as of December 31, 2020, of $750,000 for each NEO. The amount paid for Mr. Chang’s term life
insurance policy was $11,061. This column also includes $9,265 in tax payments associated with Mr. Napierski’s income received as a result of his former expatriate assignment. For further discussion regarding tax payments, see “Executive
Compensation: Compensation Discussion and Analysis—Perquisites and Other Benefits.” Portions of Mr. Napierski’s tax payments were paid in Japanese yen. The amounts were converted to U.S. dollars using a weighted average exchange rate for the
month in which the payment was made. During 2020, these exchange rates ranged from 103.8 to 109.9 Japanese yen per U.S. dollar.
|
Grants of Plan-Based Awards – 2020
The following table provides information about equity and non-equity incentive plan awards granted to each NEO in 2020.
|
Estimated Possible Payouts
under non-Equity Incentive Plan
Awards
|
Estimated Future Payouts
under Equity Incentive Plan
Awards
|
||||||||||
|
Name
|
Grant
Date(1)
|
Date of
Executive
Compensation
Committee
Approval
|
Threshold
($)(2)
|
Target
($)(2)
|
Max
($)(2)
|
Threshold
(#)(3)
|
Target
(#)(3)
|
Max
(#)(3)
|
All Other
Stock
Awards:
Number
of Shares
of Stock
or Units
(#)
|
Exercise
or Base
Price of
Option
Awards
($)(4)
|
Grant Date
Fair Value
of Stock
and
Option
Awards
($)(5)
|
|
Ritch N. Wood
|
|||||||||||
|
2/15/2020
|
2/7/2020
|
122,236
|
244,471
|
488,942
|
30.45
|
2,100,006
|
|||||
|
6/3/2020
|
2/7/2020
|
45,978
|
1,642,334
|
||||||||
|
N/A
|
137,500
|
1,100,000
|
2,200,000
|
||||||||
|
Mark H. Lawrence
|
|||||||||||
|
2/15/2020
|
2/7/2020
|
34,925
|
69,849
|
139,698
|
30.45
|
600,003
|
|||||
|
6/3/2020
|
2/7/2020
|
13,137
|
469,254
|
||||||||
|
N/A
|
49,219
|
393,750
|
787,500
|
||||||||
|
Ryan S. Napierski
|
|||||||||||
|
2/15/2020
|
2/7/2020
|
52,911
|
105,821
|
211,642
|
30.45
|
909,002
|
|||||
|
6/3/2020
|
2/7/2020
|
19,902
|
710,899
|
||||||||
|
N/A
|
90,625
|
725,000
|
1,450,000
|
||||||||
|
Joseph Y. Chang
|
|||||||||||
|
2/15/2020
|
2/7/2020
|
24,797
|
49,593
|
99,186
|
30.45
|
426,004
|
|||||
|
6/3/2020
|
2/7/2020
|
9,327
|
333,160
|
||||||||
|
N/A
|
63,281
|
506,250
|
1,012,500
|
||||||||
|
D. Matthew Dorny
|
|||||||||||
|
2/15/2020
|
2/7/2020
|
24,797
|
49,593
|
99,186
|
30.45
|
426,004
|
|||||
|
6/3/2020
|
2/7/2020
|
9,327
|
333,160
|
||||||||
|
N/A
|
47,813
|
382,500
|
765,000
|
||||||||
| (1) |
Equity awards having a grant date of 2/15/2020 and all non-equity incentive plan awards were granted pursuant to our Second Amended and Restated 2010 Omnibus Incentive Plan. Equity awards having a grant date of
6/3/2020 were pursuant to our Third Amended and Restated 2010 Omnibus Incentive Plan, with each grant contingent upon stockholder approval of that Plan. Stockholder approval occurred at our 2020 Annual Meeting of Stockholders on 6/3/2020.
|
| (2) |
The amounts reported in these columns reflect potential payouts under our 2020 executive cash incentive plan if the respective levels of performance were achieved for the year. The amounts reported in the Threshold
column reflect the potential payout if any company performance metric was at the minimum level required to receive a bonus. The amounts reported in the Target and Max columns reflect the potential payout if all company performance metrics
were at goal and maximum performance levels, respectively.
|
| (3) |
The awards reported in these columns are performance-based stock options granted under our Second Amended and Restated 2010 Omnibus Incentive Plan. The amounts reported in the Threshold, Target and Max columns
reflect the potential number of options that become eligible for vesting or exercisable if certain financial metrics are achieved at the minimum, goal and maximum levels, respectively.
|
| (4) |
This column shows the exercise price for the stock option awards, which is the closing price of our stock on the grant date or, if the grant date was a weekend or holiday, the last preceding date on which a closing
price was reported.
|
| (5) |
The amounts reported in this column reflect the aggregate grant date fair value of equity awards computed in accordance with FASB ASC Topic 718 and, for performance-based awards, are based on the probable outcome of
the performance conditions as of the grant date. For this purpose, the estimate of forfeitures is disregarded, and the value of the stock awards is discounted to reflect that no dividends are paid prior to vesting. For information on the
valuation assumptions used in calculating these amounts, refer to Note 9 to our financial statements in the Form 10-K filed for the fiscal year ended December 31, 2020.
|
Narrative to Summary Compensation Table and Grants of Plan-Based Awards Table
Employment Agreement with Mr. Chang
We have an executive employment agreement with Mr. Chang. Among other things, this agreement provides that:
| − |
Time-based equity awards granted to Mr. Chang will fully vest upon certain terminations of employment within six months prior to and in connection with, or within two years following, a change in control;
|
| − |
Mr. Chang will be bound by certain covenants, including non-solicitation, non-competition and non-endorsement, that are in addition to, or supersede, previous key employee covenants;
|
| − |
Mr. Chang will be entitled to certain termination payments, as described in “Executive Compensation Tables and Accompanying Narrative—Potential Payments Upon Termination or Change in Control” below.
|
Equity Awards and Non-Equity Incentive Plan Awards
For information on the terms of the equity awards and non-equity incentive plan awards that were granted to NEOs during 2020, see “Executive Compensation: Compensation Discussion and Analysis” and the
footnotes to the Outstanding Equity Awards at Fiscal Year-End – 2020 table. The NEOs received actual bonuses for fiscal year 2020 in the amounts shown in the "Non-Equity Incentive Plan Compensation" column of the 2020 Summary Compensation Table.
Outstanding Equity Awards at Fiscal Year-End – 2020
The following table provides information on each NEO’s holdings of equity awards as of December 31, 2020.
|
Option Awards
|
Stock Awards
|
|||||||
|
Name
and
Award
Type
(1)
|
Grant
Date
|
Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#)
|
Number of
Securities
Underlying
Unexercised
Options
Unexercisable
(#)
|
Equity Incentive
Plan Awards:
Number of
Securities
Underlying
Unexercised
Unearned Options
(#)(2)(3)
|
Option
Exercise
Price
($)
|
Option
Expiration
Date
|
Number of
Shares or
Units of
Stock That
Have Not
Vested
(#)(4)
|
Market Value
of Shares or
Units of
Stock That
Have Not
Vested
($)(5)
|
|
Ritch N. Wood
|
||||||||
|
SO
|
3/31/2014
|
6,800
|
82.85
|
3/31/2021
|
||||
|
SO
|
12/17/2014
|
6,800
|
39.51
|
12/17/2021
|
||||
|
SO
|
3/10/2015
|
6,800
|
54.97
|
3/10/2022
|
||||
|
SO
|
12/18/2015
|
6,800
|
37.58
|
12/18/2022
|
||||
|
SO
|
3/2/2016
|
136,600
|
30.63
|
3/2/2023
|
||||
|
PSO
|
3/2/2016
|
54,525
|
30.63
|
3/2/2023
|
||||
|
PSO
|
3/4/2017
|
58,306
|
50.68
|
3/4/2024
|
||||
|
RSU
|
3/4/2017
|
6,300
|
344,169
|
|||||
|
PSO
|
3/8/2018
|
41,753
|
17,253
|
71.99
|
3/8/2025
|
|||
|
RSU
|
3/8/2018
|
4,444
|
242,776
|
|||||
|
PSO
|
2/15/2019
|
35,571
|
63.09
|
2/15/2026
|
||||
|
RSU
|
2/15/2019
|
16,643
|
909,207
|
|||||
|
PSO
|
2/15/2020
|
488,942
|
30.45
|
2/15/2027
|
||||
|
RSU
|
6/3/2020
|
45,978
|
2,511,778
|
|||||
|
Mark H. Lawrence
|
||||||||
|
PSO
|
3/27/2017
|
14,422
|
54.23
|
3/27/2024
|
||||
|
RSU
|
3/27/2017
|
2,050
|
111,992
|
|||||
|
PSO
|
3/8/2018
|
11,742
|
4,853
|
71.99
|
3/8/2025
|
|||
|
RSU
|
3/8/2018
|
1,250
|
68,288
|
|||||
|
PSO
|
2/15/2019
|
9,147
|
63.09
|
2/15/2026
|
||||
|
RSU
|
2/15/2019
|
4,280
|
233,816
|
|||||
|
RSU
|
2/15/2019
|
18,493
|
1,010,273
|
|||||
|
PSO
|
2/15/2020
|
139,698
|
30.45
|
2/15/2027
|
||||
|
RSU
|
6/3/2020
|
13,137
|
717,674
|
|||||
|
Ryan S. Napierski
|
||||||||
|
SO
|
12/18/2015
|
6,800
|
37.58
|
12/18/2022
|
||||
|
SO
|
12/18/2015
|
50,000
|
37.58
|
12/18/2022
|
||||
|
SO
|
3/2/2016
|
77,800
|
30.63
|
3/2/2023
|
||||
|
PSO
|
3/2/2016
|
30,913
|
30.63
|
3/2/2023
|
||||
|
PSO
|
3/4/2017
|
32,224
|
50.68
|
3/4/2024
|
||||
|
RSU
|
3/4/2017
|
2,600
|
142,038
|
|||||
|
PSO
|
3/8/2018
|
18,919
|
7,818
|
71.99
|
3/8/2025
|
|||
|
RSU
|
3/8/2018
|
2,014
|
110,025
|
|||||
|
PSO
|
2/15/2019
|
15,398
|
63.09
|
2/15/2026
|
||||
|
RSU
|
2/15/2019
|
7,204
|
393,555
|
|||||
|
PSO
|
2/15/2020
|
211,642
|
30.45
|
2/15/2027
|
||||
|
RSU
|
6/3/2020
|
19,902
|
1,087,246
|
|||||
|
Option Awards
|
Stock Awards
|
|||||||
|
Name
and
Award
Type
(1)
|
Grant
Date
|
Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#)
|
Number of
Securities
Underlying
Unexercised
Options
Unexercisable
(#)
|
Equity Incentive
Plan Awards:
Number of
Securities
Underlying
Unexercised
Unearned Options
(#)(2)(3)
|
Option
Exercise
Price
($)
|
Option
Expiration
Date
|
Number of
Shares or
Units of
Stock That
Have Not
Vested
(#)(4)
|
Market Value
of Shares or
Units of
Stock That
Have Not
Vested
($)(5)
|
|
Joseph Y. Chang
|
||||||||
|
SO
|
3/31/2014
|
6,800
|
82.85
|
3/31/2021
|
||||
|
SO
|
3/10/2015
|
6,800
|
54.97
|
3/10/2022
|
||||
|
SO
|
12/18/2015
|
6,800
|
37.58
|
12/18/2022
|
||||
|
SO
|
3/2/2016
|
90,600
|
30.63
|
3/2/2023
|
||||
|
PSO
|
3/2/2016
|
42,485
|
30.63
|
3/2/2023
|
||||
|
PSO
|
3/4/2017
|
18,562
|
50.68
|
3/4/2024
|
||||
|
RSU
|
3/4/2017
|
1,125
|
61,459
|
|||||
|
PSO
|
3/8/2018
|
9,264
|
3,828
|
71.99
|
3/8/2025
|
|||
|
RSU
|
3/8/2018
|
986
|
53,865
|
|||||
|
PSO
|
2/15/2019
|
7,216
|
63.09
|
2/15/2026
|
||||
|
RSU
|
2/15/2019
|
3,376
|
184,431
|
|||||
|
PSO
|
2/15/2020
|
99,186
|
30.45
|
2/15/2027
|
||||
|
RSU
|
6/3/2020
|
9,327
|
509,534
|
|||||
|
D. Matthew Dorny
|
||||||||
|
SO
|
3/31/2014
|
5,000
|
82.85
|
3/31/2021
|
||||
|
SO
|
12/17/2014
|
4,900
|
39.51
|
12/17/2021
|
||||
|
SO
|
3/10/2015
|
5,000
|
54.97
|
3/10/2022
|
||||
|
SO
|
12/18/2015
|
6,000
|
37.58
|
12/18/2022
|
||||
|
SO
|
3/2/2016
|
52,000
|
30.63
|
3/2/2023
|
||||
|
PSO
|
3/2/2016
|
41,235
|
30.63
|
3/2/2023
|
||||
|
PSO
|
3/4/2017
|
18,562
|
50.68
|
3/4/2024
|
||||
|
RSU
|
3/4/2017
|
1,125
|
61,459
|
|||||
|
PSO
|
3/8/2018
|
9,264
|
3,828
|
71.99
|
3/8/2025
|
|||
|
RSU
|
3/8/2018
|
986
|
53,865
|
|||||
|
PSO
|
2/15/2019
|
7,216
|
63.09
|
2/15/2026
|
||||
|
RSU
|
2/15/2019
|
3,376
|
184,431
|
|||||
|
PSO
|
2/15/2020
|
99,186
|
30.45
|
2/15/2027
|
||||
|
RSU
|
6/3/2020
|
9,327
|
509,534
|
|||||
| (1) |
Award types are as follows:
|
|
SO: Time-Based Stock Options
|
|
RSU: Time-Based Restricted Stock Units
|
|
PSO: Performance-Based Stock Options
|
| (2) |
Performance-Based Stock Options vest in three equal tranches based on the achievement of adjusted EPS performance levels, measured in terms of diluted EPS excluding certain predetermined items. Vesting occurs on
the later of one year following the grant date and the Committee’s approval of the calculation of adjusted EPS for the respective tranche. Vesting of the target amount of PSOs is accelerated upon the participant’s termination (including
constructive termination) in connection with a change in control. Any portions of the tranches that do not become eligible for vesting will immediately terminate following the later of one year following the grant date and the Committee’s
approval of the calculation of adjusted EPS for such tranche.
|
|
Grant Date
|
Vesting Schedule
|
|
3/8/2018
|
A portion of the first tranche vested based on adjusted EPS achieved in 2018. No portion of the second or third tranche vested based on adjusted EPS achieved in 2020, and these tranches
therefore terminated as of February 7, 2020 and February 10, 2021, respectively.
|
|
2/15/2019
|
No portion of the first or second tranche vested based on adjusted EPS achieved in 2019 and 2020, and these tranches therefore terminated as of February 15, 2020 and February 10, 2021. The
portion of the third tranche that vests will be determined by adjusted EPS reaching pre-determined levels in 2021.
|
|
2/15/2020
|
The first tranche vested in full based on adjusted EPS achieved in 2020. The portions of the second and third tranches that vest will be determined by adjusted EPS reaching pre-determined levels
in 2021 and 2022, respectively.
|
| (3) |
In accordance with SEC rules, these columns report the potential number of options that become eligible for vesting or exercisable if performance is at the minimum level required for any options to become eligible
for vesting or exercisable, except that, based on 2020 results, the PSOs granted on 2/15/2020 are reported at the maximum level.
|
| (4) |
Time-Based Restricted Stock Units
|
|
Grant Date
|
Vesting Schedule
|
|
3/4/2017
|
Vest in four equal annual installments, the first of which vested on March 4, 2018.
|
|
3/27/2017
|
Vest in four equal annual installments, the first of which vested on March 2, 2018.
|
|
3/8/2018
|
Vest in four equal annual installments, the first of which vested on February 15, 2019.
|
|
2/15/2019
|
Vest in four equal annual installments, the first of which vested on February 15, 2020, except for Mr. Lawrence’s award of 18,493 RSUs, which vests in three equal annual
installments, the first of which vested on February 15, 2020.
|
|
6/3/2020
|
Vest in four equal annual installments, the first of which vested on February 15, 2021.
|
| (5) |
The market value of the restricted stock units reported in these columns is based on the closing market price of our stock on December 31, 2020, which was $54.63.
|
Option Exercises and Stock Vested – 2020
The following table provides information on stock option exercises and vesting of stock awards for each NEO during 2020.
|
Option Awards
|
Stock Awards
|
|||
|
Name
|
Number of Shares Acquired on Exercise (#)(1)
|
Value Realized on Exercise ($)(2)
|
Number of Shares Acquired on Vesting (#)
|
Value Realized on Vesting
($)(3)
|
|
Ritch N. Wood
|
—
|
—
|
14,070
|
397,688
|
|
Mark H. Lawrence
|
—
|
—
|
13,348
|
394,762
|
|
Ryan S. Napierski
|
48,000
|
1,046,951
|
6,009
|
170,286
|
|
Joseph Y. Chang
|
6,800
|
72,478
|
2,744
|
78,065
|
|
D. Matthew Dorny
|
18,600
|
382,943
|
2,744
|
78,065
|
| (1) |
All option exercises were pursuant to Rule 10b5-1 trading plans adopted by the NEOs.
|
| (2) |
Value realized on exercise of stock options is equal to the number of options exercised multiplied by the market value of our common stock at exercise less the exercise price, and is calculated before payment of any
applicable withholding taxes and broker commissions.
|
| (3) |
Value realized on vesting of restricted stock units is equal to the number of restricted stock units vested multiplied by the market value of our common stock on the vesting date, and is calculated before payment of
any applicable withholding taxes and broker commissions.
|
Nonqualified Deferred Compensation
Pursuant to our nonqualified Deferred Compensation Plan (the "DCP"), certain employees, including the NEOs, may elect to defer up to 80% of their base salary and up to 100% of cash incentive bonus
(minus applicable withholding requirements) that otherwise would be payable in a calendar year. Deferral elections are made prior to the calendar year in which the deferred salary or bonus will be earned. In addition, the company makes contributions
to each NEO’s account. Effective in 2021, the DCP was modified to provide a matching contribution by the company for individual contributions up to a maximum of 5% of base salary. We also generally make a discretionary contribution, expected to be
reduced from the historical amount of 10% of salary to approximately 5% of salary.
Earnings and losses on deferred base salary and bonus are based on market rates, mirroring the performance of investment funds that are available for participants to track under the DCP. All amounts a
participant elects to defer, adjusted for earnings and losses thereon, are 100% vested for purposes of the DCP at all times. All amounts we contribute, adjusted for earnings and losses thereon, either vest 20% per year over five years (for
contributions on or after January 1, 2021) or vest over a 20-year period that begins on the participant's hire date (for contributions prior to 2021). This vesting schedule is subject to acceleration upon the occurrence of certain events, including
the attainment of 60 years of age, death or disability as defined in the DCP, discretionary acceleration by the Committee, or, for contributions on or after January 1, 2021, the completion of at least 10 years of employment above a specified
compensation level.
For participants who received company contributions prior to January 1, 2015, the DCP also provides a death benefit that will pay, upon a participant’s death prior to the commencement of benefit
payments, an amount equal to the participant’s deferrals, adjusted for earnings and losses thereon, plus the greater of (i) the vested portion of company contributions, adjusted for earnings and losses thereon, or (ii) five times such participant’s
average base salary for the previous three years. All distributions under the DCP are payable in cash (except for restricted stock units, which were previously permitted to be deferred and are payable in stock), and the participant may elect either a
lump sum payment or monthly, quarterly, or annual installments over a maximum of 15 years.
The following table shows the investment funds that are available for participants to track under the DCP and their annual rates of return for the fiscal year ended December 31, 2020, as reported by the
administrator of the DCP.
|
Name of Fund
|
Rate of
Return
|
Name of Fund
|
Rate of
Return
|
|
Great-West Gov't Money Market - Instl Shares
|
0.41%
|
Neuberger Berman AMT Mid-Cap Intrinsic Value - I Class
|
-2.62%
|
|
American Century VP Inflation Protection - Class I Shares
|
9.81%
|
LVIP SSgA Mid-Cap Index - Standard Class
|
13.19%
|
|
Vanguard VIF Short-Term Investment-Grade
|
5.49%
|
Great-West T. Rowe Price Mid Cap Growth - Investor Class
|
24.11%
|
|
LVIP Delaware Bond - Standard Class
|
9.87%
|
Delaware VIP Small Cap Value Series - Standard Class
|
-1.90%
|
|
Putnam VT High Yield - Class IA
|
5.50%
|
DWS VIT Small Cap Index VIP - Class A
|
19.43%
|
|
Templeton Global Bond VIP - Class 1
|
-5.07%
|
Vanguard VIF Small Company Growth
|
23.18%
|
|
Great-West Conservative Profile - Investor Class
|
8.21%
|
American Funds Global Growth - Class 2
|
30.47%
|
|
Great-West Moderately Conservative Profile - Investor Class
|
9.57%
|
American Funds IS Global Growth and Income - Class 2
|
8.73%
|
|
Great-West Moderate Profile - Investor Class
|
11.25%
|
American Funds Global Small Capitalization - Class 2
|
29.73%
|
|
Great-West Moderately Aggressive Profile - Investor Class
|
11.75%
|
AB VPS International Value - Class A
|
2.47%
|
|
Great-West Aggressive Profile - Investor Class
|
11.99%
|
American Funds International - Class 2
|
13.98%
|
|
Delaware VIP Value Series - Standard Class
|
0.41%
|
Van Eck VIP Emerging Markets - Initial Class
|
17.25%
|
|
MFS VIT Value - Initial Class
|
3.48%
|
Vanguard VIF Real Estate Index
|
-4.85%
|
|
Vanguard VIF Equity Index
|
18.20%
|
MFS VIT Utilities Series - Initial Class
|
5.90%
|
|
Vanguard VIF Growth
|
43.09%
|
Nu Skin Enterprises Inc. Restricted Stock Units
|
39.04%
|
|
Delaware VIP U.S. Growth Series - Standard Class
|
44.13%
|
Nonqualified Deferred Compensation – 2020
The following table provides information on each NEO’s account under our nonqualified Deferred Compensation Plan for the year 2020.
|
Name
|
Executive
Contributions
in Last FY
($)(1)
|
Registrant
Contributions
in Last FY
($)(1)
|
Aggregate
Earnings
in Last FY
($)(1)
|
Aggregate
Withdrawals/
Distributions
|
Aggregate
Balance at
Last FYE
($)(1)
|
|
|
Ritch N. Wood
|
—
|
100,000
|
214,246
|
—
|
1,744,394
|
|
|
Mark H. Lawrence
|
11,303
|
52,500
|
48,627
|
—
|
303,401
|
|
|
Ryan S. Napierski
|
301,830
|
72,500
|
1,052,084
|
—
|
5,612,008
|
|
|
Joseph Y. Chang
|
—
|
67,500
|
1,055,902
|
—
|
9,828,757
|
|
|
D. Matthew Dorny
|
450,898
|
51,000
|
112,667
|
—
|
2,619,790
|
|
| (1) |
Executive and registrant contribution amounts are and have been reflected in the 2020 Summary Compensation Table and prior years’ summary compensation tables, as applicable. Aggregate earnings are not reflected in
the 2020 Summary Compensation Table and were not reflected in prior years’ summary compensation tables.
|
Potential Payments Upon Termination or Change in Control
The information below describes the compensation that would become payable under existing plans and arrangements if the NEO’s employment had terminated on December 31, 2020, given each NEO’s
compensation and service level as of such date and, if applicable, based on our closing stock price on that date. Except as noted below, all amounts would be payable as a lump sum upon termination, except deferred compensation, which may be payable
as a lump sum or in installments at the election of the NEO. These benefits are in addition to benefits available generally to salaried employees, such as disability benefits and distributions under our 401(k) plan.
Due to the number of factors that affect the nature and amount of any benefits provided upon the events discussed below, any actual amounts paid or distributed may be different. Factors that could
affect these amounts include the timing during the year of any such event, our stock price and the NEO’s age.
|
Name
|
Voluntary Termination ($)
|
Involuntary Termination for Cause ($)
|
Involuntary Termination Not for Cause ($)
|
Termination (Including Constructive Termination) in Connection with Change of Control ($)
|
Death ($)(1)
|
Disability ($)
|
|
Ritch N. Wood
|
||||||
|
Severance(2)
|
750,000
|
—
|
3,266,600
|
5,966,600
|
1,766,600
|
2,016,600
|
|
Equity(3)
|
—
|
—
|
—
|
9,919,239
|
—
|
—
|
|
Deferred Compensation(4)
|
1,744,394
|
1,744,394
|
1,744,394
|
1,744,394
|
4,888,953
|
1,744,394
|
|
Health Benefits(5)
|
—
|
—
|
26,246
|
26,246
|
—
|
—
|
|
Total
|
2,494,394
|
1,744,394
|
5,037,239
|
17,656,478
|
6,655,553
|
3,760,994
|
|
Mark H. Lawrence
|
||||||
|
Severance(2)
|
393,750
|
—
|
1,288,613
|
2,010,488
|
632,363
|
763,613
|
|
Equity(3)
|
—
|
—
|
—
|
3,830,991
|
—
|
—
|
|
Deferred Compensation(4)
|
61,577
|
61,577
|
61,577
|
61,577
|
61,577
|
297,077
|
|
Health Benefits(5)
|
—
|
—
|
26,460
|
26,460
|
—
|
—
|
|
Total
|
455,327
|
61,577
|
1,376,650
|
5,929,516
|
693,940
|
1,060,690
|
|
Ryan S. Napierski
|
||||||
|
Severance(2)
|
543,750
|
—
|
2,070,600
|
3,339,350
|
1,164,350
|
1,345,600
|
|
Equity(3)
|
—
|
—
|
—
|
2,585,781
|
—
|
—
|
|
Deferred Compensation(4)
|
5,379,138
|
5,379,138
|
5,379,138
|
5,379,138
|
7,754,399
|
5,379,138
|
|
Health Benefits(5)
|
—
|
—
|
25,879
|
25,879
|
—
|
—
|
|
Total
|
5,922,888
|
5,379,138
|
7,475,618
|
11,330,149
|
8,918,749
|
6,724,738
|
|
Joseph Y. Chang
|
||||||
|
Severance(2)
|
1,368,750
|
—
|
2,519,288
|
3,447,413
|
813,038
|
981,788
|
|
Equity(3)
|
—
|
—
|
—
|
2,008,448
|
—
|
—
|
|
Deferred Compensation(4)
|
9,828,757
|
9,828,757
|
9,828,757
|
9,828,757
|
11,038,198
|
9,828,757
|
|
Health Benefits(5)
|
—
|
—
|
16,475
|
16,475
|
—
|
—
|
|
Total
|
11,197,507
|
9,828,757
|
12,364,520
|
15,301,092
|
11,851,236
|
10,810,545
|
|
D. Matthew Dorny
|
||||||
|
Severance(2)
|
382,500
|
—
|
1,251,795
|
1,953,045
|
614,295
|
741,795
|
|
Equity(3)
|
—
|
—
|
—
|
2,008,448
|
—
|
—
|
|
Deferred Compensation(4)
|
2,312,642
|
2,312,642
|
2,312,642
|
2,312,642
|
3,670,572
|
2,312,642
|
|
Health Benefits(5)
|
—
|
—
|
26,460
|
26,460
|
—
|
—
|
|
Total
|
2,695,142
|
2,312,642
|
3,590,897
|
6,300,595
|
4,284,867
|
3,054,437
|
| (1) |
The amounts reported in this column do not include the proceeds payable on death from term life insurance policies for which we pay the premiums, with coverage, as of December 31, 2020, of $750,000 for each NEO.
|
| (2) |
Our Executive Severance Policy applies to all of the NEOs. This policy provides for the following termination payments in addition to salary and benefits earned prior to termination, provided that the NEO complies
with certain non-competition and other obligations:
|
(a) Voluntary termination:
(i) A lump sum equal to 75% of annual salary if the Company elects, in its sole discretion, to enforce the non-competition obligations in the NEO’s Key Employee Covenants
Agreement.
(b) Involuntary termination not for cause (including constructive termination):
(i) The pro-rata portion of the NEO’s earned bonus, if any, for any outstanding bonus cycle, payable at the same time as bonuses are paid to other executive officers; and
(ii) A lump sum equal to a multiplier (of 1.5 for the CEO; 1.25 for other NEOs) times annual salary.
(c) Termination (including constructive termination) in connection with a change in control:
(i) The pro-rata portion of the NEO’s earned bonus, if any, for any outstanding bonus cycle, payable at the same time as bonuses are paid to other executive officers; and
(ii) A lump sum equal to a multiplier (of 2 for the CEO; 1.5 for other NEOs) times the sum of annual salary and target bonus.
(d) Termination upon death or disability:
(i) The pro-rata portion of the NEO’s earned bonus, if any, for any outstanding bonus cycle, payable on the date that bonuses are normally paid; and
(ii) Salary continuation for up to 90 days in certain circumstances related to a disability.
In addition, Mr. Chang’s employment agreement provides that, if his employment terminates pursuant to any of the circumstances outlined above in this footnote 2, other than for
death or disability, Mr. Chang will be entitled to a four-year consulting agreement with us for $287,500 per year, less any severance payments that are paid to him during the year pursuant to the Executive Severance Policy.
| (3) |
Our equity award agreements generally provide that unvested awards will terminate upon the termination of employment. However, vesting (of the target amount, in the case of performance-based stock options) is
accelerated upon the participant’s termination (including constructive termination) in connection with a change in control. Accordingly, the amounts payable under the equity category, in the case of performance-based stock option awards,
are based on the difference between the $54.63 closing price of our stock on December 31, 2020 and the exercise price of the applicable award, multiplied by the target number of unvested options subject to the award. The amounts payable
under the equity category in the case of time-based restricted stock units are based on the same closing price multiplied by the number of unvested restricted stock units subject to the applicable award.
|
| (4) |
The amounts reported for deferred compensation, other than for death and disability, reflect only the amounts deferred by the NEOs, the vested portion of amounts contributed by us and earnings on such amounts. We
may, at our discretion, accelerate vesting of the unvested amounts contributed by us in the event of a change in control. If we were to accelerate vesting, the total amounts of deferred compensation payable to our NEOs would be as follows:
Mr. Wood – $1,744,394; Mr. Lawrence – $297,077; Mr. Napierski – $5,379,138; Mr. Chang – $9,828,757; and Mr. Dorny – $2,312,642.
|
| (5) |
Our Executive Severance Policy entitles the NEOs to a lump sum equal to twelve months of health care continuation coverage upon involuntary termination not for cause (including constructive termination) and
termination (including constructive termination) in connection with change in control. These payments are conditioned on the NEO’s compliance with certain non-competition and other obligations.
|
The following table provides information as of December 31, 2020, about our Class A Common Stock that may be issued upon the exercise of options, warrants and rights under all of our existing equity
compensation plans (including individual arrangements):
|
Plan Category
|
Number of securities
to be issued upon
exercise of
outstanding options,
warrants and rights
(a)
|
Weighted-average
exercise price of
outstanding
options, warrants
and rights
(b)
|
Number of securities
remaining available for
future issuance under
equity compensation plans
(excluding securities
reflected in column (a))
(c)
|
|
Equity compensation plans approved by security holders
|
4,099,717(1)
|
$44.76(2)
|
5,817,529(3)
|
|
Equity compensation plans not approved by security holders
|
—
|
—
|
—
|
|
Total
|
4,099,717
|
$44.76
|
5,817,529
|
(1) Consists of 3,168,691 options (770,631 time-based and 2,398,060 performance-based) and 931,026 restricted stock units (931,026 time-based and 0
performance-based). The performance-based awards are reported as the number of shares that become eligible for vesting or exercisable if performance is at the target level. The number of shares that are ultimately issued pursuant to the
performance-based awards could vary from the amounts reported based on the degree to which the performance goals are achieved.
(2) Excludes the impact of time-based and performance-based restricted stock units, which are exercised for no consideration. The weighted average remaining
life of the options is 4.2 years.
(3) Represents the number of shares available for future issuance under our Third Amended and Restated 2010 Omnibus Incentive Plan, under which we may grant
awards relating to shares of Class A Common Stock including options, stock appreciation rights, restricted stock awards, restricted stock unit awards, other share-based awards and performance awards. Options and stock appreciation rights are
counted against the share reserve as one share for each option or stock appreciation right. Other awards are counted as 2.25 shares.
As required by the Dodd-Frank Wall Street Reform and Consumer Protection Act and SEC rules, we are disclosing the annual total compensation of the CEO, the median of the annual total compensation of all
other employees, and the ratio of these two numbers (the “CEO pay ratio”), each as calculated pursuant to applicable rules and guidance. We also provide supplemental information and calculations to provide context regarding our global operations and
unique features of our workforce.
CEO Compensation
Mr. Wood’s 2020 annual total compensation was $6,636,559.
Median Employee Compensation and CEO Pay Ratio Disclosure
As of December 31, 2020, our global employee population, including employees of our subsidiaries, consisted of 25,789 individuals. To identify the median employee, we used each employee’s annualized
base pay plus target cash incentive as of December 31, 2020 (for Mainland China sales employees, described below, and employees of our manufacturing and packaging subsidiaries, this was calculated by annualizing their salary and bonus amounts for the
last portion of the year, as those amounts are indicative of their recent activity), translated into U.S. dollars. With these amounts for all of our employees, we identified a median group of 101 employees. We then calculated the annual total
compensation of each of these 101 employees using the same methodology that is required under SEC disclosure requirements for our NEOs’ compensation, and we identified the median employee from that population.
Our median employee is a sales employee in Mainland China whose 2020 annual compensation was $1,339, which yields a CEO pay ratio of 4,956:1. However, as discussed below, due to a unique feature of our
employee population, we do not believe this ratio appropriately represents our company’s compensation practices.
Supplemental Information – Global Employee Population and Structure
The structure of our business model in Mainland China causes a unique and significant increasing impact on our CEO pay ratio. In all of our markets other than Mainland China, our sales force members are
independent distributors rather than employees of our company. Because of restrictions on direct selling and multi-level commissions in Mainland China, we have implemented a business model for that market that is different from our business model in
other markets. One of the differences is that our sales force in Mainland China includes not only independent sellers but also part-time sales employees.
Our Mainland China sales employees constitute a large proportion of our total employee base, and as a result, these employees have a significant impact on our CEO pay ratio. As of December 31, 2020,
20,999, or 81%, of our employees were Mainland China sales employees, compared to 4,790 other full- and part-time employees worldwide. Like all members of our sales force globally, our Mainland China sales employees devote as much or as little time
and effort to their sales efforts as they desire, and their compensation varies significantly as a result.
Due to the impact of our Mainland China sales employees on our CEO pay ratio, we do not believe the required pay ratio disclosure, above, appropriately represents our company’s compensation practices.
To better allow stakeholders to evaluate our CEO’s compensation within the context of our company, we also disclose a ratio that excludes our Mainland China sales employees. Based on our 4,790 employees who are not Mainland China sales employees, our
median employee is a communication specialist in Hong Kong whose 2020 annual compensation was $36,226, resulting in a CEO pay ratio of 183:1.
We believe the compensation amounts and ratios provided above represent reasonable estimates calculated in accordance with SEC regulations and guidance. The SEC rules allow companies to adopt a variety
of methodologies, to apply certain exclusions, and to make reasonable estimates and assumptions that reflect their employee populations and compensation practices. As a result, the pay ratio reported by other companies may not be comparable to the
pay ratio for our company, as other companies have different employee populations and compensation practices and may utilize different methodologies, exclusions, estimates and assumptions in calculating their pay ratios.
ADVISORY VOTE TO APPROVE OUR EXECUTIVE COMPENSATION
Pursuant to Section 14A of the Securities Exchange Act of 1934, as amended, we are requesting stockholder approval of a non-binding advisory resolution approving our NEOs’ compensation as disclosed in
this proxy statement.
Compensation Objectives and 2020 Pay for Performance
The following objectives of our executive compensation program support our recommendation to approve the compensation of our NEOs:
| (1) |
Our program enables us to successfully recruit, motivate and retain experienced and talented executives;
|
| (2) |
We implement a pay-for-performance philosophy through the use of incentives that:
|
| a. |
Are tied to corporate and individual performance;
|
| b. |
Align the financial interests of our executives with those of our stockholders; and
|
| c. |
Drive superior stockholder value.
|
The program, which is administered by our Executive Compensation Committee (the “Committee”), is intended to align actual compensation payments to actual performance and to adjust upward during periods
of strong performance and downward when performance is short of expectations.
Amidst a challenging year, our revenue increased 7% in 2020 to $2.58 billion, while earnings per share improved 17% to $3.63. Both our customer and sales leader numbers improved during the year,
increasing 34% and 29%, respectively. These improvements came as a result of focusing on our growth strategy and capitalizing on opportunities available to us through our prior investments in product innovation, technology and manufacturing to build
our customer base and empower our sales leaders. We experienced strong growth in our Americas/Pacific, EMEA and Manufacturing segments. Additionally, we strengthened our balance sheet, repurchased more than five million shares of stock and increased
our dividend for the 19th consecutive year.
We continue to believe we have the correct growth strategy in place to achieve revenue growth and expand our customer base. Our executive compensation program and the pay-for-performance incentives that
are built into it are key drivers of management’s motivation.
| − |
2020 compensation was predominantly variable. Consistent with our commitment to pay for performance, our CEO’s 2020 target compensation consisted of 82%
variable compensation (cash incentive bonus and equity awards) and 18% fixed compensation (salary and all other compensation). Our other NEOs’ target compensation was 71% variable and 29% fixed.
|
| − |
2020 equity awards were predominantly performance-based. The equity awards that were granted to our NEOs in 2020 also reflect our pay-for-performance
philosophy. These equity awards were approximately 60% performance-based (based on grant date fair value). Going forward, the Committee generally plans to continue using an equity mix of approximately 60% performance-based awards.
|
Advisory Resolution
The Board of Directors recommends that stockholders approve the following advisory resolution:
RESOLVED, that the stockholders hereby approve the compensation of the company’s named executive officers, as disclosed in this proxy statement pursuant to Item 402 of Regulation S-K,
including the Compensation Discussion and Analysis, compensation tables and narrative disclosure.
Although this advisory resolution is non-binding, the Board values input from stockholders. The Board will consider the voting results for this proposal in making future compensation decisions.
We currently intend to include a stockholder advisory resolution on our executive compensation program at our annual meeting of stockholders each year.
THE BOARD OF DIRECTORS RECOMMENDS THAT STOCKHOLDERS VOTE “FOR” THE APPROVAL OF THE ADVISORY RESOLUTION APPROVING OUR EXECUTIVE COMPENSATION.
RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Our Audit Committee is directly responsible for the appointment, compensation, retention and oversight of our independent registered public accounting firm. The Audit Committee is also involved in the
selection of the lead audit engagement partner whenever a rotational change is required, normally every five years.
PricewaterhouseCoopers LLP (“PwC”) served as our independent registered public accounting firm for the 2020 fiscal year. PwC has served in this capacity since the 1994 fiscal year, and the Audit
Committee has selected PwC to serve in this capacity for the 2021 fiscal year. The Audit Committee believes that the continued retention of PwC as our independent registered public accounting firm for 2021 is in the best interests of our company and
our stockholders. Before determining to retain PwC for 2021, the Audit Committee evaluated PwC’s performance and qualifications, considering such factors as technical competence, independence, adequacy of staffing the audit, quality and efficiency of
services, expertise with our company and industry, reasonableness of fees, and quality and candor of communications. The Audit Committee also considered the potential impact a change in our auditors could have on our company and audit.
As a matter of good corporate governance, we are asking stockholders to ratify the selection of PwC as our independent registered public accounting firm for 2021. If the selection is not ratified, the
Audit Committee will consider whether it is appropriate to select another independent registered public accounting firm. Even if the selection is ratified, the Audit Committee in its discretion may select a different registered public accounting firm
at any time during the year if it determines that such a change would be in the best interests of us and our stockholders.
Representatives of PwC are expected to be present at the Annual Meeting. They will have the opportunity to make a statement if they so desire and will be available to respond to appropriate questions.
The following table presents approximate fees for professional services rendered by PwC for the audit of our annual financial statements for the 2019 and 2020 fiscal years and approximate fees billed
for other services rendered by PwC during those periods.
|
Fiscal 2020 ($)
|
Fiscal 2019 ($)
|
|
|
Audit Fees(1)
|
3,070,000
|
3,132,000
|
|
Audit-Related Fees(2)
|
23,000
|
355,000
|
|
Tax Fees(3)
|
1,577,000
|
1,398,000
|
|
All Other Fees(4)
|
3,000
|
7,000
|
|
Total
|
4,673,000
|
4,892,000
|
| (1) |
Audit Fees consist of fees billed or expected to be billed for the audit of annual financial statements, review of quarterly financial statements and services normally provided in connection with statutory and
regulatory filings or engagements.
|
| (2) |
Audit-Related Fees for 2020 consist primarily of fees related to testing for acquisitions and the preparation of certain documents. Audit-Related Fees for 2019 consist primarily of (1) reviews and evaluations of
our system implementations and methodologies related to the adoption of new accounting standards and tax reform; and (2) services in connection with our debt refinance and acquisitions.
|
| (3) |
Tax Fees for 2020 consist of approximately $1,206,000 in fees for tax compliance work and $371,000 in fees for tax planning work. Tax Fees for 2019 consist of approximately $1,085,000 in fees for tax compliance
work and $313,000 in fees for tax planning work.
|
| (4) |
All Other Fees consist of access fees to accounting, financial and disclosure resources.
|
Under the Audit and Non-Audit Services Pre-Approval Policy, the Audit Committee must pre-approve all audit and non-audit services provided by the independent registered public accounting firm. The
policy, as described below, sets forth the procedures and conditions for such pre-approval of services to be performed by the independent registered public accounting firm. Under the policy, proposed services may be either pre-approved categorically
within specified budgets (“general pre-approval”) or specifically pre-approved on a case-by-case basis (“specific pre-approval”). In approving any services by the independent registered public accounting firm, the Audit Committee will consider
whether the performance of any such service would impair the independent registered public accounting firm’s independence. The policy also authorizes the Audit Committee chair to provide pre-approval for services, provided that she or he reports the
pre-approval to the Audit Committee at its next scheduled meeting.
The Audit Committee must specifically pre-approve the terms and fees of each annual audit services engagement. All other Audit, Audit-Related, Tax, and All Other Services (each defined in the policy)
may be generally pre-approved pursuant to projected categorical budgets. The Audit services subject to general pre-approval include such services as statutory audits or financial audits for subsidiaries or affiliates and services associated with SEC
registration statements, periodic reports, and other documents filed with the SEC or other documents issued in connection with securities offerings. Audit-related services are assurance and related services that are reasonably related to the
performance of the audit or review of our financial statements or that are traditionally performed by the independent registered public accounting firm. Tax services include tax compliance, tax planning, and tax advice. All Other Services are those
routine and recurring services that the Audit Committee believes will not impair the independence of our registered public accounting firm. The SEC prohibits our independent registered public accounting firm from performing certain non-audit
services, and under no circumstances will the Audit Committee approve such services.
The Audit Committee will review the generally pre-approved services from time to time, at least annually. Any changes to budgeted amounts or proposed services will require specific pre-approval by the
Audit Committee.
The Audit Committee approved the engagement of PwC to audit our 2020 consolidated financial statements before the engagement began, and in 2020, all of the Audit-Related, Tax and All Other services
provided by PwC were approved by the Audit Committee in accordance with the Audit and Non-Audit Services Pre-Approval Policy.
The Audit Committee is responsible for monitoring our financial auditing, accounting, and financial reporting processes and our system of internal controls on behalf of the Board. Our management has
primary responsibility for our internal controls and reporting process. Our independent registered public accounting firm, PricewaterhouseCoopers LLP (“PwC”), is responsible for performing an independent audit of our consolidated financial statements
and the effectiveness of our internal control over financial reporting in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”) and issuing an opinion thereon. The Audit Committee’s responsibility is
to monitor these processes. In this context, the Audit Committee met and held discussions with management, our internal auditors and PwC. Management represented to the Audit Committee that the consolidated financial statements for the fiscal year
2020 were prepared in accordance with generally accepted accounting principles.
The Audit Committee hereby reports as follows:
| − |
The Audit Committee has reviewed and discussed the audited consolidated financial statements and accompanying management’s discussion and analysis of financial condition and results of operations with our management
and PwC. This discussion included PwC’s judgments about the quality, not just the acceptability, of the accounting principles, the reasonableness of significant judgments, and the clarity of disclosures in the financial statements.
|
| − |
The Audit Committee has discussed with PwC the matters required to be discussed by the applicable requirements of the PCAOB and the Securities and Exchange Commission.
|
| − |
PwC also provided to the Audit Committee the written disclosures and the letter required by applicable requirements of the PCAOB regarding PwC’s communications with the Audit Committee concerning independence, and
the Audit Committee has discussed with PwC the accounting firm’s independence. The Audit Committee also considered whether non-audit services provided by PwC during the last fiscal year were compatible with maintaining the accounting firm’s
independence.
|
| − |
Based on the review and discussions referred to above, the Audit Committee recommended to the Board that the audited consolidated financial statements be included in our Annual Report on Form 10‑K for the year ended
December 31, 2020, for filing with the Securities and Exchange Commission.
|
|
AUDIT COMMITTEE OF THE BOARD OF
DIRECTORS
|
|
|
Edwina D. Woodbury, Chair
|
|
|
Daniel W. Campbell
|
|
|
Thomas R. Pisano
|
THE BOARD OF DIRECTORS RECOMMENDS THAT STOCKHOLDERS VOTE “FOR” RATIFICATION OF THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR
2021.
Review and Approval of Related-Person Transactions
Our Audit Committee Charter requires that the Audit Committee review related-person transactions that are significant in size and relevant to an understanding of our financial statements, and approve or
reject such transactions. The Charter further requires the Audit Committee to review the policies and procedures utilized by management for the implementation of such transactions. The Charter provides that the Committee has delegated the review and
approval or rejection of related-person employment matters to the Executive Compensation Committee.
We have adopted a written policy and procedures with respect to related-person transactions, which include specific provisions for the approval of related-person transactions. Pursuant to this policy,
related-person transactions include a transaction, arrangement or relationship in which we and certain enumerated related persons participate and the amount involved exceeds $25,000.
In the event that a related-person transaction is identified, it must be reviewed and approved or ratified by our Audit Committee. If it is impracticable for our Audit Committee to review the
transaction, the transaction will be reviewed by the chair of our Audit Committee if the amount involved is less than $120,000, whereupon the chair of our Audit Committee will report to the Audit Committee the approval or disapproval of the
transaction.
In reviewing and approving related-person transactions, the Audit Committee or its chair is required to consider all information that the Audit Committee or its chair believes to be reasonable in light
of the circumstances. The Audit Committee or its chair, as the case may be, shall approve only those related-person transactions that are determined to be in, or not inconsistent with, our best interests and those of our stockholders, as the Audit
Committee or its chair determines in good faith. No member of the Audit Committee shall participate in any review, consideration or approval of any related-person transaction with respect to which the member or any of his or her immediate family
members has an interest.
Related-Person Transactions
Employee Family Members. During 2020, we paid employment compensation in excess of $120,000 to one relative of each of Steve Lund,
Ritch Wood, and Ryan Napierski.
| − |
Eric Lund, the brother of Steve Lund, received approximately $144,000 in salary, bonuses and other compensation and 571 restricted stock units.
|
| − |
Ryan Wood, the brother of Ritch Wood, received approximately $404,000 in salary, bonuses and other compensation, 2,571 restricted stock units and 3,905 performance-based stock options.
|
| − |
Cade Napierski, the brother of Ryan Napierski, received approximately $689,000 in salary, bonuses, expatriate benefits (including an education and housing allowance and other benefits) and other compensation, 1,507
restricted stock units and 2,289 performance-based stock options.
|
These three individuals also participated in the employee benefit plans available generally to our employees.
The following table sets forth certain information regarding the beneficial ownership of our Class A Common Stock as of April 5, 2021, except where the footnotes to the table indicate a different date.
Unless otherwise indicated in the footnotes to the table, the stockholders listed have direct beneficial ownership and sole voting and investment power with respect to the shares beneficially owned. For each individual and group included in the table
below, percentage ownership is calculated by dividing the number of shares beneficially owned by such person or group by the sum of the 50,134,073 shares of Class A Common Stock outstanding on April 5, 2021 plus the number of shares of Class A Common
Stock that such person or group had the right to acquire within 60 days after April 5, 2021.
|
Directors, Executive Officers, 5% Stockholders
|
Number of
Shares(1)
|
Percent of
Class
|
|
Ritch N. Wood(2)
|
635,127
|
1.3%
|
|
Ryan S. Napierski
|
301,087
|
*
|
|
Joseph Y. Chang(3)
|
300,334
|
*
|
|
Steven J. Lund(4)
|
246,328
|
*
|
|
D. Matthew Dorny(5)
|
189,612
|
*
|
|
Daniel W. Campbell(6)
|
115,822
|
*
|
|
Andrew D. Lipman(7)
|
92,747
|
*
|
|
Mark H. Lawrence
|
92,426
|
*
|
|
Thomas R. Pisano(8)
|
65,968
|
*
|
|
Zheqing (Simon) Shen
|
16,987
|
*
|
|
Edwina D. Woodbury(9)
|
14,518
|
*
|
|
Laura Nathanson
|
6,490
|
*
|
|
All directors and executive officers as a group (12 persons)
|
2,077,445
|
4.0%
|
|
Emma S. Battle
|
—
|
*
|
|
BlackRock Inc.(10)
|
5,271,188
|
10.5%
|
|
The Vanguard Group(11)
|
4,828,238
|
9.6%
|
|
Wellington Management Group LLP(12)
|
3,174,336
|
6.3%
|
|
Renaissance Technologies LLC(13)
|
2,723,596
|
5.4%
|
| * |
Less than 1%
|
| (1) |
Includes shares that the above individuals have the right to acquire within 60 days as follows: Mr. Wood – 495,098; Mr. Napierski – 253,196; Mr. Chang – 220,619; Mr. Lund – 0; Mr. Dorny – 156,469; Mr. Campbell –
23,612; Mr. Lipman – 23,612; Mr. Lawrence – 72,726; Mr. Pisano – 18,612; Mr. Shen – 8,612; Ms. Woodbury – 8,612; Ms. Nathanson – 3,612; all directors and executive officers as a group – 1,284,780; and Ms. Battle – 0.
|
| (2) |
Includes 2,000 shares that Mr. Wood jointly owns with family members.
|
| (3) |
Includes 78,068 shares held in a trust for which Mr. Chang’s spouse serves as trustee and for which Mr. Chang and his spouse are beneficiaries.
|
| (4) |
Includes 240,692 shares held by a family limited liability company for which Mr. and Mrs. Lund serve as co-managers and share voting and investment power. Also includes 5,636 shares held indirectly by Mr. and Mrs.
Lund as co-trustees with respect to which they share voting and investment power.
|
| (5) |
Includes 29,559 shares that are held in a revocable trust for which Mr. and Mrs. Dorny act as co-trustees and share voting and investment power.
|
| (6) |
Includes 82,200 shares that Mr. Campbell jointly owns with his spouse and 10,010 shares held by a family limited liability company owned and controlled by Mr. Campbell and his spouse.
|
| (7) |
Includes 2,535 shares that Mr. Lipman jointly owns with his spouse and 15,400 shares that are held in a revocable trust for which Mr. Lipman and his spouse act as co-trustees and share voting and investment power.
|
| (8) |
Includes 47,356 shares that Mr. Pisano jointly owns with his spouse.
|
| (9) |
In addition to the shares reported in the table above, Ms. Woodbury has elected to defer receipt of an additional 1,459 shares pursuant to the company’s Deferred Compensation Plan.
|
| (10) |
Based on a Schedule 13G/A filed by BlackRock, Inc. with the SEC on January 27, 2021 and disclosing ownership information as of December 31, 2020. According to the Schedule 13G/A, BlackRock, Inc. has sole voting
power for 5,092,390 shares and sole dispositive power for 5,271,188 shares. The address of BlackRock, Inc. is 55 East 52nd Street, New York, NY 10055.
|
| (11) |
Based on a Schedule 13G/A filed by The Vanguard Group with the SEC on February 10, 2021 and disclosing ownership information as of December 31, 2020. According to the Schedule 13G/A, The Vanguard Group has sole
voting power for 0 shares, sole dispositive power for 4,752,826 shares, shared voting power for 34,155 shares, and shared dispositive power for 75,412 shares. The address of The Vanguard Group is 100 Vanguard Blvd, Malvern, PA 19355.
|
| (12) |
Based on a Schedule 13G/A filed by Wellington Management Group LLP and related entities with the SEC on February 4, 2021 and disclosing ownership information as of December 31, 2020. According to the Schedule
13G/A, Wellington Management Group LLP and related entities beneficially own shares as follows:
|
|
Entity
|
Shared Voting
Power
|
Shared
Dispositive
Power
|
Aggregate
Amount
Beneficially
Owned
|
|
Wellington Management Group LLP
|
2,949,765
|
3,174,336
|
3,174,336
|
|
Wellington Group Holdings LLP
|
2,949,765
|
3,174,336
|
3,174,336
|
|
Wellington Investment Advisors Holdings LLP
|
2,949,765
|
3,174,336
|
3,174,336
|
|
Wellington Management Company LLP
|
2,883,774
|
3,037,912
|
3,037,912
|
The address of these entities is c/o Wellington Management Company LLP, 280 Congress Street, Boston, MA 02210.
| (13) |
Based on a Schedule 13G filed by Renaissance Technologies LLC and a related entity with the SEC on February 10, 2021 and disclosing ownership information as of November 12, 2020. According to the Schedule 13G,
both Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation, as the majority owner of Renaissance Technologies LLC, have sole voting power for 2,720,796 shares and sole dispositive power for 2,723,596 shares. The
address of both entities is 800 Third Avenue, New York, New York 10022.
|
Section 16(a) of the Securities Exchange Act of 1934, as amended, requires our directors, executive officers and persons who beneficially own more than 10% of our Class A Common Stock to file reports
with the SEC regarding their ownership of our Class A Common Stock and changes in that ownership. Based solely on a review of the reports filed during or with respect to 2020 and on written representations from our directors and executive officers,
we believe that all required reports under Section 16(a) were filed on a timely basis, except for (i) one late report for Ms. Woodbury related to one transaction; and (ii) one late report for Mr. Lipman related to four dividend reinvestment
transactions that occurred during 2018 for a total of 35 shares.
In order for a stockholder proposal to be considered for inclusion in our proxy statement for our 2022 annual meeting, the written proposal must be received at our principal executive offices no later
than the close of business on December 22, 2021. Proposals should be addressed to: Corporate Secretary, Nu Skin Enterprises, Inc., 75 West Center Street, Provo, Utah 84601. Such proposals also will need to comply with the requirements contained in
our Bylaws and SEC regulations regarding the inclusion of stockholder proposals in company-sponsored proxy materials.
Any stockholder proposal, including any director nomination, that is not submitted for inclusion in our 2022 proxy statement under SEC regulations, but is instead sought to be presented directly at our
2022 annual meeting, must be received by the Corporate Secretary at the above address no later than January 21, 2022. However, if the date of our 2022 annual meeting is changed by more than 30 days from the one-year anniversary of our 2021 Annual
Meeting, a stockholder’s notice must be received by our Corporate Secretary at the above address not later than the close of business on the later of (a) the 90th day before the 2022 annual meeting or (b) the 10th day following the day on which
public announcement of the date of such meeting is first made. In addition, if the number of directors to be elected is increased and there has been no public announcement naming all of the nominees for director or indicating the increase in the size
of the Board at least 10 days before the last day a stockholder may deliver a notice of nomination in accordance with the preceding sentences, then with respect to nominees for any new positions created by such increase, the notice must be received
by the Corporate Secretary at the above address no later than the close business on the 10th day following the day on which public announcement is first made by us. In addition, all notices must meet all information and other requirements contained
in our Bylaws.
To obtain a copy of the relevant Bylaw provisions regarding the requirements for making stockholder proposals and nominating director candidates, a stockholder may contact our Corporate Secretary at our
headquarters, 75 West Center Street, Provo, Utah 84601.
We may deliver a single notice of internet availability or set of proxy materials to an address shared by two or more of our stockholders. This delivery method, referred to as “householding,” can result
in significant cost savings for us. To take advantage of this opportunity, the company and banks and brokerage firms that hold your shares may deliver only one notice of internet availability or set of proxy materials to multiple stockholders who
share an address unless one or more of the stockholders has provided contrary instructions. The company will deliver promptly, upon written or oral request, a separate copy of the notice of internet availability or set of proxy materials to a
stockholder at a shared address to which a single copy of the documents was delivered. A stockholder who wishes to receive a separate notice of internet availability or set of proxy materials, now or in the future, may obtain one, without charge, by
addressing a request to Investor Relations, Nu Skin Enterprises, Inc., 75 West Center Street, Provo, Utah 84601 or by calling (801) 345-1000. Stockholders of record sharing an address who are receiving multiple copies of these materials and wish to
receive a single copy of such materials in the future should submit their request by contacting us in the same manner. If you are the beneficial owner, but not the record holder, of the company’s shares and wish to receive only one copy of the notice
of internet availability or set of proxy materials in the future, you will need to contact your broker, bank or other nominee to request that only a single copy of each document be mailed to all stockholders at the shared address in the future.
This proxy statement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended,
that represent the company’s current expectations and beliefs. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws and include, but are not limited to, statements
of management’s expectations regarding the company's strategies, initiatives and future management, as well as statements regarding future compensation decisions and performance. In some cases, you can identify these statements by forward-looking
words such as “believe,” “expect,” “anticipate,” “determine,” “estimate,” “intend,” “plan,” “targets,” “likely,” “will,” “would,” “could,” “may,” “might,” the negative of these words and other similar words. The forward-looking statements and related
assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, political,
legal, tax and regulatory uncertainties; any failure of current or planned initiatives or products to generate interest among the company’s sales force and customers and generate sponsoring and selling activities on a sustained basis; competitive
pressures for personnel; and the possibility that management or the Executive Compensation Committee could decide not to follow the company’s compensation program as described in the Compensation Discussion and Analysis. The company’s performance and
the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the SEC. The forward-looking statements set forth the company’s beliefs as of the
date that such information was first provided, and the company assumes no duty to update the forward-looking statements contained in this proxy statement to reflect any change except as required by law.
As of the date of this proxy statement, the Board of Directors knows of no other matters to be brought before the Annual Meeting. If you return your signed and completed proxy card or vote by telephone
or on the internet and other matters are properly brought before the Annual Meeting or any adjournment or postponement thereof, the persons named in the enclosed proxy will have discretionary authority to vote for you on such matters in accordance
with their best judgment, acting together or separately.
A copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as filed with the Securities and Exchange Commission, without exhibits, may be obtained by
stockholders without charge by written request to Investor Relations, Nu Skin Enterprises, Inc., 75 West Center Street, Provo, Utah 84601. A copy of the Annual Report on Form 10-K is also available on our Investor Relations website at ir.nuskin.com. Exhibits will be provided upon written request and payment of an appropriate processing fee.
By Order of the Board of Directors,
STEVEN J. LUND
Chairman of the Board
Provo, Utah
